<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Helikon Consulting on Medium]]></title>
        <description><![CDATA[Stories by Helikon Consulting on Medium]]></description>
        <link>https://medium.com/@admin-21183?source=rss-a4e32a83d306------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*8Q29Fu3gWnggxWxn8XjIiA.png</url>
            <title>Stories by Helikon Consulting on Medium</title>
            <link>https://medium.com/@admin-21183?source=rss-a4e32a83d306------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 23:12:54 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@admin-21183/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Regulation of new food ingredients: Is it GRAS?]]></title>
            <link>https://admin-21183.medium.com/regulation-of-new-food-ingredients-is-it-gras-941d1a44523d?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/941d1a44523d</guid>
            <category><![CDATA[food-additives]]></category>
            <category><![CDATA[food-ingredients]]></category>
            <category><![CDATA[alternative-protein]]></category>
            <category><![CDATA[synthetic-biology]]></category>
            <category><![CDATA[regulatory-compliance]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Tue, 07 Jun 2022 14:28:41 GMT</pubDate>
            <atom:updated>2022-06-07T14:44:45.475Z</atom:updated>
            <content:encoded><![CDATA[<p>In the US, any new food ingredient is subject to premarket FDA approval via a Food Additive Petition unless it is generally recognized as safe (GRAS) by qualified experts for its intended use or it does not meet the definition of a food additive (such as color additives). Importantly, the same US regulatory process and standards of safety apply for ingredients developed using genetic engineering techniques as for those developed using conventional techniques. Here, we provide an overview of food ingredient safety determination &amp; GRAS process, along with case studies using examples from the food tech industry.</p><p><strong>FOOD ADDITIVE PETITION</strong></p><p>The process for food additive safety determination was established by the 1958 Food Additives Amendment to the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act). <a href="https://www.fda.gov/food/generally-recognized-safe-gras/how-us-fdas-gras-notification-program-works">Food additives</a> are defined as “any substance the intended use of which results or may reasonably be expected to result, directly or indirectly, in its becoming a component or otherwise affecting the component of food”. Ingredients that are GRAS, or generally recognized as safe, are not considered food additives and do not require FDA premarket approval.</p><p>A <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-questions-and-answers-about-food-additive-or-color-additive-petition-process#answerI">food additive petition</a> is submitted to the FDA to request an assessment of a new food additive. The food additive safety assessment involves a toxicology, chemistry, and environmental review. The petition must contain all supporting information &amp; original scientific data, including details on the identity, proposed use, and probable exposure levels under the proposed use, as well as any pertinent study reports (i.e. including raw toxicological data). Once the petition is submitted, it takes at least <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-questions-and-answers-about-food-additive-or-color-additive-petition-process#:~:text=The%20average%20time%20between%20submission,the%20approval%20process%20varies%20significantly.">two years</a> for the FDA to make a final determination. Examples of food additives include <a href="https://www.fda.gov/food/food-additives-petitions/food-additive-status-list">antibiotics</a> used in meat and meat by-products (i.e. bacitracin, ampicillin) and xanthan gum used as an emulsifier in cheese and animal feed. Generally, the food additive approval route is chosen if special safety controls need to be in place either for the manufacturing process or the intended use.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*K0_gnxkymoG9mV-J" /></figure><p>New food substances are exempt from premarket FDA approval if the substance is “generally recognized as safe” (GRAS). In order for a substance to be <a href="https://www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras">GRAS</a>, there must be a consensus amongst qualified experts on the safety of the substance under the conditions of its intended use.</p><p>GRAS determination is made by scientists who are qualified to make the determination. The determination is often supported by a panel of independent experts, typically convened by a company, who independently review the assessment by the company of the safety of the substance based on publicly available scientific data and information. The pivotal information to form the basis of the GRAS conclusion has to be in the public domain, and preferably in peer-reviewed publications. This is in contrast to a food additive safety determination, which is performed by the FDA, often based on confidential data and information submitted directly to FDA.</p><p>Upon completion of a self-GRAS determination, companies may submit a notice to the FDA to support their self-GRAS conclusion through <a href="https://www.fda.gov/food/generally-recognized-safe-gras/how-us-fdas-gras-notification-program-works">FDA’s GRAS Notification Program</a>. Through this program, companies voluntarily inform the FDA of their GRAS self-determination with the goal of receiving a “No Questions Letter”. The notification procedure generally consists of the following steps:</p><ol><li><strong>Industry submits a GRAS notification to the FDA</strong>. The GRAS notification contains information on the identity and proposed use of the substance, and a discussion on the basis for GRAS determination. The notification must also contain references to all supporting information &amp; scientific data, including any pertinent studies.</li><li><strong>FDA reviews the GRAS notice</strong> to determine whether the notice provides sufficient basis for the submitter’s GRAS determination. FDA review time typically ranges from <a href="https://www.fda.gov/food/generally-recognized-safe-gras/fdas-approach-gras-provision-history-processes">6–9 months</a> although recently it has taken FDA longer due to heavy workload.</li><li><strong>FDA response</strong>. The FDA may: 1) respond with a No Questions Letter to the GRAS determination, 2) conclude that there is a lack of sufficient basis for GRAS determination, or 3) cease to evaluate at the notifier’s request. FDA generally offers option 3) to the submitter and utilizes option 2) only if the submitter does not request the FDA to cease evaluating the GRAS Notice.</li></ol><p><strong>Case study: Perfect Day’s B-lactoglobulin</strong></p><p>Perfect Day submitted a GRAS notice for their recombinantly produced B-lactoglobulin in May 2019. The protein is intended for use as a source of protein in food (i.e. as a substitute for traditional whey protein) and is produced in <em>Trichoderma reesei</em>, a filamentous fungi commonly used for industrial protein production.<em> </em>After the notice was filed by the FDA approximately one month after receipt as GRAS Notice 813, there was a seven month period of correspondence between Perfect Day and the FDA in which the FDA sought additional information about the identity, manufacturing specifications, and intended use of the protein product.</p><p>In March 2020, about 10 months from the time the GRAS notice was submitted, the FDA issued a “<a href="https://www.fda.gov/media/136751/download">Letter of No Questions</a>’’ about Perfect Day’s conclusion that its recombinantly produced B-lactoglobulin is GRAS under its intended conditions of use. The letter summarizes the identity of the subject of the notice, how it is constructed/manufactured, the method of validating the identity/composition, method of use, and Perfect Day’s basis for GRAS: 1). use of a non-toxigenic, non-pathogenic production host, <em>Trichoderma reesei</em>, with a history of safe use in producing food enzymes), and 2) production of a non-allergenic food protein with a long history of use in food. The letter additionally remarks on requirements regarding food and allergen labeling.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/1*Y1OWiDeYKIQLFMby2-6Nbw.png" /></figure><p><strong>Case study: Impossible Foods’ soy leghemoglobin</strong></p><p>The <a href="https://www.fda.gov/media/124351/download">initial GRAS notice</a> for Impossible Foods’ soy leghemoglobin (SLH) produced from <em>Pichia Pastoris </em>was submitted in September 2014 and filed the same month by the FDA as GRN 540. In this initial filing, the main justifications for IF’s self-affirmed GRAS determination were 1) the similarity between soybean leghemoglobin and other commonly consumed plant and animal hemoglobin, and 2) an extensive history of safe use/consumption of soy and other globin proteins.</p><p>After some <a href="https://1bps6437gg8c169i0y1drtgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/08/072717_Impossible_Burger_FOIA_documents.pdf">correspondence</a> with IF, the FDA concluded that contrary to IF’s argument, structural/functional similarities between SLH and other, commonly consumed proteins is not sufficient for establishing the safety of SLH for human consumption. The FDA additionally remarked that not all globin proteins are safe for human consumption, and that the history of the safe use of soy proteins referenced in the notice refers to the use of soy proteins from soybeans and not the use of soy leghemoglobin from soybean plant roots. IF thus requested the FDA to cease evaluation of its GRAS notice in November 2015.</p><p>In October 2017, after conducting <em>in vitro </em>genotoxicity and rodent toxicity studies, IF submitted the <a href="https://www.fda.gov/media/116243/download">second GRAS notice</a> for its soy leghemoglobin protein. The second notice included references to the new <em>in vitro </em>and animal studies assessing the toxicity and mutagenicity of SLH. FDA filed the notice that same month as GRN 737. The FDA responded with a request for clarification about the use of the soy leghemoglobin preparation and IF filed several amendments to its GRAS Notice. In July 2018, the agency issued a letter stating that it had no further questions about IF’s GRAS determination. The letter included additional notes on allergen labeling. In addition, as there is no GRAS provision for color additives and IF’s SLH might be used as a color additive. FDA informed IF of the potential need for a Color Additive Petition since SLH is red/brown in color. Indeed, in October 2018, IF submitted a petition to use SLH as a color additive in food, which it had to do in order to sell plant based burgers to consumers in retail stores where its color functionality is key, and the CAP was approved by the FDA in August 2019.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/1*KJA8Kls_sI9UMPO4f3XMpg.png" /></figure><p><strong>Conclusion</strong></p><p>Food ingredients may achieve regulatory compliance through GRAS determination or through a food additive petition. These regulatory processes primarily differ in terms of 1) who has access to the scientific data and 2) who reviews the scientific data and other supporting information, and ultimately makes the final determination. A food additive safety determination is made by the FDA based on data included as part of the petition. In contrast, GRAS determination is made by the company, and may be supported by a panel of experts convened by the company or may leverage peer-reviewed safety data and information. A GRAS self-conclusion may be further supported by voluntary GRAS notification followed by an FDA “No Questions Letter”. As exemplified by the case studies, the time from initial notification to an FDA No Questions Letter may vary, but achieving GRAS status typically takes less time than achieving a food additive safety determination. Understanding the different regulatory processes for food ingredients can help ensure timely compliance with regulatory requirements and support transparency in the supply chain and to consumers.</p><p><em>Written by Wei Ng, PhD candidate &amp; Helikon Associate. Many thanks to </em><a href="https://www.linkedin.com/in/vincesewalt/details/experience/"><em>Vince Sewalt</em></a><em> for constructive dialogue and feedback!</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=941d1a44523d" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Cell-cultured food products: US co-regulatory framework & path towards establishing a labeling…]]></title>
            <link>https://admin-21183.medium.com/cell-cultured-food-products-us-co-regulatory-framework-path-towards-establishing-a-labeling-94b630465345?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/94b630465345</guid>
            <category><![CDATA[alternative-protein]]></category>
            <category><![CDATA[lab-grown-meat]]></category>
            <category><![CDATA[cell-cultured-meat]]></category>
            <category><![CDATA[synthetic-biology]]></category>
            <category><![CDATA[cell-culture-protein]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Tue, 07 Jun 2022 13:58:59 GMT</pubDate>
            <atom:updated>2022-06-07T13:58:59.615Z</atom:updated>
            <content:encoded><![CDATA[<h3>Cell-cultured food products: US co-regulatory framework &amp; path towards establishing a labeling standard</h3><p>Cellular agriculture companies are sprinting to develop cell-cultured meat, or meat derived from growing animal cells in laboratories. Before these new foods get to our plate, however, manufacturers will need to demonstrate that both the manufacturing process and final cell-cultured product satisfies labeling &amp; regulatory requirements and meets the necessary standards of safety. Here, we provide an overview of current US regulations/guidelines and an outlook on the future of regulating cell-based food.</p><p><strong>US co-regulatory framework for cell-cultured food products</strong></p><p>In March of 2019, the FDA and the Food Safety and Inspection Service of the USDA <a href="https://www.fda.gov/food/domestic-interagency-agreements-food/formal-agreement-between-fda-and-usda-regarding-oversight-human-food-produced-using-animal-cell">formally agreed</a> to <a href="https://www.fda.gov/food/food-ingredients-packaging/food-made-cultured-animal-cells">co-regulate</a> cell-cultured products depending on 1) the type of cell line comprising the product and 2) stage in manufacture.</p><p>Cell-cultured products comprising cell lines derived from animals that are 1) intended for human consumption and 2) currently regulated by the USDA will be subject to co-regulation by the FDA and USDA depending on the stage of manufacture. This includes cell-cultured livestock and poultry products as specified by the Federal Meat Inspection Act and the Poultry Products Inspection Act. The FDA will provide regulatory oversight on all stages of manufacture prior to cell harvest, including tissue collection, maintenance of cell banks, and cell growth &amp; differentiation. The agency will conduct pre-market safety consultations as well as routine record and facilities inspections. Facilities must be registered with the FDA and comply with the FDA’s Current Good Manufacturing Practices and preventive control requirements. The FDA encourages participation in their <a href="https://www.fda.gov/food/food-ingredients-packaging/food-made-cultured-animal-cells">pre-market consultation process</a>.</p><p>Meanwhile, the USDA will oversee manufacturing stages downstream of cell harvest, including product processing, packaging, &amp; labeling. Additionally, the USDA will be responsible for daily inspection of facilities where cells are harvested and processed. Such establishments will be required to operate under a Grant of Inspection from USDA-FSIS and meet all FSIS regulatory requirements. Facilities must meet requirements for ensuring sanitation and have Hazard Analysis and Critical Control Points systems in place. Detailed procedures on the transfer of regulatory oversight during cell harvest are yet to be announced.</p><p>Cell-cultured products made from cell lines derived from animals that are not currently regulated by the USDA (i.e. most seafood except catfish) will be regulated solely by the FDA during both pre- and post-harvest stages of manufacture, including product labeling. Post-harvest oversight will differ substantially from that for cell-cultured meat. For example, the frequency of inspection of food facilities solely under FDA oversight will be lower.</p><p>In both cases it is foreseen that the safety of certain inputs for use in the various manufacturing steps including cell culture may be established via the GRAS process based on scientific procedures.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*LtyrhWJv_6tr5IZC" /></figure><p><strong>Labeling of cell-cultured food products</strong></p><p>Under the <a href="https://www.fda.gov/food/domestic-interagency-agreements-food/formal-agreement-between-fda-and-usda-regarding-oversight-human-food-produced-using-animal-cell">March 2019 agreement</a> (Brashears, Yiannis), the FDA and USDA-FSIS will coordinate to establish joint principles for labeling of cell-cultured food products to ensure consistency and transparency. Additionally, labeling of cell-cultured food products originating from livestock and poultry will be overseen by the FSIS-USDA, while labeling of cell cultured products originating from seafood and other animals not currently regulated by the USDA will be overseen by the FDA. Although a final labeling requirement has yet to be established, we can look to existing labeling requirements for conventional meat and public commentary on the labeling of cell-cultured meat for insight into what future regulatory requirements might look like.</p><p><strong>Existing labeling requirements for traditionally grown meat</strong></p><p>Labeling requirements for cell-cultured products will likely be influenced by their characteristics and similarity to conventional slaughtered products. Current FSIS labeling requirements for conventional slaughtered products, including the use of the terms “meat” and “poultry,” take into consideration consumer expectations with respect to the biological, chemical, nutritional, and organoleptic properties of the finished product. If a new product differs from conventional products, a new labeling standard may need to be developed.</p><p>Current labeling requirements by the FSIS allow labels that meet legal standards and do not contain special claims to be “generically approved” and exempt from FSIS review prior to commercialization. <a href="https://www.fsis.usda.gov/sites/default/files/media_file/2020-10/Label-Approval-Guide.pdf">Special claims include</a> those that are not factual statements, and lack regulatory definitions (i.e. not defined in FSIS regulations or the <a href="https://www.fsis.usda.gov/guidelines/2005-0003">Food Standards and Labeling Policy Book</a>). Generic approval typically applies for labeling statements with widespread industry and consumer understanding. Due to the novelty of cell culture technology in food, labels for cell cultured food products will thus likely be regarded as special claims in the label review process.</p><p><strong>Summary of public comments on a new labeling requirement for cell-cultured meat</strong></p><p>Previous commenting periods about the labeling of cell-cultured products reveal widespread consensus about labeling that indicates whether the product was made using cell culture technology. A <a href="https://www.federalregister.gov/documents/2020/10/07/2020-22140/labeling-of-foods-comprised-of-or-containing-cultured-seafood-cells-request-for-information">commenting period</a> for labeling of cultured seafood reflects a similar <a href="https://thespoon.tech/we-read-the-public-comments-on-cell-cultured-meat-labeling-so-you-dont-have-to/">consensus</a> — many favored labeling that distinguishes traditional farmed or wild-caught products from cell-cultured products. Other comments reflected concerns about the impact of labeling on industry innovation, the need for establishing standards of identity for cultured products, and standards for evaluating claims for cultured products. One petition advocated for a delay in establishing labeling requirements until there is a more complete understanding of the characteristics of cell-cultured products and the proposed labels.</p><p>To solicit more information and data that could potentially be used to establish a labeling requirement for cell-cultured products, the FSIS initiated a 60-day commenting period (later extended to 120 days) in <a href="https://www.federalregister.gov/documents/2021/09/03/2021-19057/labeling-of-meat-or-poultry-products-comprised-of-or-containing-cultured-animal-cells">September 2021</a>. In the commenting period, <a href="https://thespoon.tech/we-read-the-public-comments-on-cell-cultured-meat-labeling-so-you-dont-have-to/">some argued </a>against the need for new labeling requirements in the absence of significant differences in the safety or characteristics between the cell cultured and conventional products, especially due to potential negative consequences on industry innovation (Bond, Camille). Others advocated for terminology to distinguish cell cultured and conventional products, but favored waiting until there is more information on consumer perceptions of proposed labels. Additionally, there continued to be disagreement about whether “meat” could be used to describe cell-cultured products, and about the pros/cons around the use of different qualifiers to distinguish cell-cultured products from conventional products.</p><p><strong>Current regulatory review process for labels on cell-cultured products</strong></p><p>Overall, more information about proposed labels, consumer reactions to proposed labels, and characteristics of cell-cultured products will likely be important in establishing a label requirement. Periodic re-evaluation of label requirements may additionally be necessary as the development of cell-cultured products progresses and the products become more similar to conventional meat.</p><p>Until a final labeling requirement is established, labels for cultured meat will be subject to individual review and approval by FSIS. The FSIS will ensure that labels meet current standards for conventional meat and poultry products. Labeling of cell-cultured seafood and other animals not currently regulated by the USDA will be overseen by the FDA. Possible terms for labeling cell-cultured products include “cultured”, “cell-cultured”, “cultivated”, “cell-based” or “in vitro”. Although USDA and FDA will operate from joint principles for labeling cell-cultured products, specific labeling language for cell-cultured meat/poultry and seafood may, in the end, differ. Once the final rule has been made, labels approved for cell-cultured products in advance of the final rule may need to be changed accordingly.</p><p><strong>Labeling requirements for bioengineered foods</strong></p><p>Depending on the characteristics of the cell-cultured product and the origin of the cells, it is possible that it may additionally be subject to the <a href="https://www.federalregister.gov/documents/2018/12/21/2018-27283/national-bioengineered-food-disclosure-standard">National Bioengineered Food Disclosure Standard</a>, which was established by the USDA in December 2018. The deadline for mandatory compliance was January 1, 2022. This means that all foods subject to the Standard must be labeled in accordance with the Standard as of January 1, 2022, with exception for small food manufacturers, which have 1 additional year for implementation.</p><p>The Standard applies to <a href="https://www.ams.usda.gov/rules-regulations/be/bioengineered-foods-list">all foods that are bioengineered or that contain bioengineered </a>ingredients, including <strong>Arctic Apples &amp; AquaBounty Salmon</strong>. Bioengineered foods are defined as foods that contain genetic modifications that could not 1) be generated using conventional breeding techniques or 2) be found in nature. It only applies to foods of animal origin that are subject to the <a href="https://www.govinfo.gov/content/pkg/CFR-2019-title7-vol3/xml/CFR-2019-title7-vol3-part66.xml">labeling requirements of the Federal Food, Drug &amp; Cosmetic Act</a> (i,e, seafood) and does not apply to products subject to the labeling provisions of the Federal Meat Inspection Act (beef, pork, catfish) and Poultry Products Inspection Act (poultry meat and eggs). As such, bioengineered food disclosure requirements for animal cell-cultured foods only apply to seafood and potentially to cell-cultured products of certain exotic species. Also of note is that incidental additives (e.g., processing aids) are out of scope of the Bioengineered Food definition.</p><p>The Standard allows multiple different <a href="https://www.ams.usda.gov/rules-regulations/be/faq/disclosure">forms of disclosure</a> that the food product is bioengineered or contains bioengineered food products. The disclosure may be made by:</p><ol><li>text (i.e. “contains bioengineered food ingredients”),</li><li>a symbol</li><li>electronic or digital link, such as a QR code or phone number that provides access to the disclosure</li><li>text message (“Text [command word] to [number] for bioengineered food information.”)</li></ol><p>The National Bioengineered Food Disclosure Standard was established by the USDA in response to the 2016 <a href="https://www.ams.usda.gov/rules-regulations/be/faq/general">National Bioengineered Food Disclosure Standard Law</a>, which mandated that bioengineered foods be appropriately disclosed on product packaging and charged the USDA with establishing a standard for doing so. Prior to this law, labeling that indicates whether a food product is bioengineered was voluntary and overseen by the FDA.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/982/0*UnDfz8Wsk7aisVZh" /></figure><p><strong>Conclusion</strong></p><p>To guide innovators in producing cell-cultured products, regulators created a co-regulatory framework involving joint oversight of cell-cultured products by the FDA and USDA. This new framework was accompanied by a description of the regulatory review process for evaluating labeling of cell-cultured food products. Importantly, a final labeling requirement has not yet been established, and certain details of the co-regulatory framework are to be determined. Labeling and regulatory requirements may be subject to re-evaluation as more companies develop and seek commercialization for cell-cultured products.</p><p><em>Written by Wei Ng, PhD candidate &amp; Helikon Associate. Many thanks to </em><a href="https://www.linkedin.com/in/vincesewalt/details/experience/"><em>Vince Sewalt</em></a><em> for constructive dialogue and feedback!</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=94b630465345" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Synthetic biology to solve sensitive diet restrictions]]></title>
            <link>https://admin-21183.medium.com/synthetic-biology-to-solve-sensitive-diet-restrictions-4841d439d36c?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/4841d439d36c</guid>
            <category><![CDATA[alternative-protein]]></category>
            <category><![CDATA[diet-restrictions]]></category>
            <category><![CDATA[genetic-engineering]]></category>
            <category><![CDATA[synthetic-biology]]></category>
            <category><![CDATA[engineered-food]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Mon, 28 Mar 2022 14:58:53 GMT</pubDate>
            <atom:updated>2022-03-28T14:58:53.762Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*EwAh1M3CquqyiRFvWpw-GQ.png" /><figcaption>(i.e creating biotech foods that mimic the “natural” counterpart but without components that can cause biologic issues for a subset of consumers. (i.e lactose intolerance, celiac disease, eosinophilic esophagitis) where the focus is to create a product that mimics both taste and texture of animal-based products by replacing specific components)</figcaption></figure><p><strong>Intro</strong></p><p>The rapidly expanding engineered food market is gaining a lot of buzz, both with investors and future consumers. This excitement for the future of food comes with good reason. The general public views these emerging technologies as exciting because they are poised to contribute positively in addressing several key issues facing global society today: 1) Climate change through a reduction in greenhouse gas emissions associated with energy intensive animal agriculture, 2) Ethical concerns surrounding traditional slaughter practices in meat production, and 3) Water and crop usage for raising livestock and the plants that feed them. Additionally, the public seems intrigued by the science-fictionesque nature of this growing industry. But the truly exciting piece lies not just in the imaginative depictions of science fiction, but in the reality of this technology. As companies begin to dive into the research of how to recreate common food items such as meats, cheeses and even egg products, researchers are beginning to understand that recreation of these familiar foods requires a lot of engineering at the cellular and molecular levels. Because of this, a growing number of entities are realizing that merely mimicking existing products is not the only way to proceed in this industry. Rather, this industry could recreate foods from the ground up to address dietary constraints just not possible in traditional agricultural practices. This fledgling, but quickly expanding, industry is able to steer into places even sci fi writers could not have foreseen. With these innovative new ways to control our food even at the molecular level, this industry is poised to potentially solve new problems not in the market’s original vision for engineered foods.</p><p><strong>Dietary restrictions</strong></p><p>Many people in developed nations are living with some sort of dietary restriction that severely limits what they are able to safely eat. One such example would be a condition known as eosinophilic esophagitis (EoE), which is a disorder characterized by hyperinflammation to the gastrointestinal tract that is exceptionally sensitive to certain food groups. Patients coping with EoE tend to rely on dietary restrictions that follow the six-food elimination diet (SFED) that typically excludes wheat, milk, egg, nuts, soy, fish and shellfish. As many will note, these categories of food make up quite a sizable portion of western diets which makes it exceedingly difficult to adhere to these restrictions long term. Additionally, the prevalence of these food groups in western culture, and cultures worldwide, will make accidental ingestion highly likely. With the advent of engineered foods, researchers have a unique opportunity to rebuild the foods we crave from the ground up. The use of synthetic biology to modify the starting material to remove or replace allergens while preserving characteristic flavors and textures is similar to how a molecular understanding of celiac disease spurred the use of culinary techniques to produce gluten free breads.</p><p><strong>Synthetic Biology</strong></p><p>Synthetic biology is an interdisciplinary field that aims to take what we know about genetics and cellular physiology to leverage precise gene editing tools such as CRISPR and TALEN editing packages to <a href="https://pubmed.ncbi.nlm.nih.gov/16951971/">control behavior of living cells</a> through their genetics. By treating genetic pathways as tunable and editable circuits, cells can be made into factories for all kinds of goods. Additionally, combining these powerful editing tools in addition to big data driven <a href="https://irp.nih.gov/catalyst/v19i6/systems-biology-as-defined-by-nih">systems biology</a>, researchers have never had more control and understanding of complex biological systems. Many companies are using synthetic biology to take control of biological systems to <a href="https://glycosyn.com/">become molecular factories</a> or even build up the bulk <a href="https://finlessfoods.com/">material of food products</a>. Various groups around the world are leveraging this new field of biology to recreate staple foods by <a href="https://www.foodnavigator.com/Article/2021/02/03/Better-Dairy-Alt-milk-start-up-taps-precision-fermentation-to-disrupt-dairy">rebuilding dairy</a> from the molecule up. In doing so, these companies are beginning to think about how they can move beyond merely mimicking “natural” counterparts to these products. By taking a “ground up” approach, researchers are beginning to realize they do not need to limit themselves to only following what traditional agriculture has been able to provide. The tools of synthetic biology allow for much more discreet control of these biologic systems where everything from the <a href="http://balleticfoods.com/">protein up</a> can be designed for a unique and nutritious product.</p><p><strong>Engineered Foods</strong></p><p>Some of the first attempts at producing engineered foods using synthetic biology toolkits were in plant agriculture. These products were designed to address a variety of concerns from <a href="https://citrusindustry.net/2019/12/19/niche-market-and-dooryard-citrus-for-the-hlb-world/">protecting crops from invasive pathogens</a> to creating a food product to fill a much needed <a href="https://www.goldenrice.org/">gap in local diets</a>. These triumphs really demonstrated, as a proof of concept, the capacity of engineered foods to solve problems at all points of the supply chain. These products can address concerns from the production process to the nutritional value provided to our diets. As this technology evolved, the emerging market of engineered meats is finally <a href="https://www.theguardian.com/food/2020/jan/19/cultured-meat-on-its-way-to-a-table-near-you-cultivated-cells-farming-society-ethics">hitting maturity</a>. Stem cell reprogramming technology allows for scientists to take a small biopsy from animals commonly used as livestock and turn them back into stem cells. This is done through the introduction of stem cell factors that are able to “reset” the epigenetic landscape of the genome make the cells behave like embryonic stem cells. What is attractive about these cells is their inherent ability to divide theoretically indefinitely, without reaching a phase of replicative exhaustion known as senescence. Additionally, these stem cells maintain the ability to transform [differentiate] into any cell type of the body. Using these unique features of stem cells would allow industries to create genetically identical [autogenic] cell components of all sorts of meat products. Stem cells can be used to make skeletal muscle that makes up many of our favorite meat cuts such as <a href="https://aleph-farms.com/">steaks</a>, <a href="https://newagemeats.com/">pork chops</a>, and <a href="http://memphismeats.com/">chicken breasts</a>. These cells can be further refined with the addition of other cell types responsible for the flavor of the livestock produced product such as fat [adipose].</p><p><strong>Conclusions</strong></p><p>By leveraging these approaches of synthetic biology and genetic engineering truly allows for scientists to recreate food from the ground up, and to create it in ways never before imaginable. Similar cuts of meat can be reimagined to have higher protein or nutrient content, altered lipid ratios, lower cholesterol or even take a page from plant agricultural feats, such as golden rice, to introduce nutrients generally missing from local diets into foods people naturally want to eat. It also allows for creations that can circumvent common dietary restrictions due to allergens while finding new ways to preserve that texture and flavor that people love. The unprecedented leverage the cell agriculture space has on designing food down to the molecular level offers a bright and exciting future for food, both from a scientific and consumer perspective.</p><p><strong>Written by Chris Anderson, Associate</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4841d439d36c" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Metabolic Engineering: Cannabinoids]]></title>
            <link>https://admin-21183.medium.com/metabolic-engineering-cannabinoids-c5c7490a080c?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/c5c7490a080c</guid>
            <category><![CDATA[cannabinoid-oil]]></category>
            <category><![CDATA[fermentation]]></category>
            <category><![CDATA[cannabinoids]]></category>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[metabolic-engineering]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Mon, 28 Mar 2022 14:50:35 GMT</pubDate>
            <atom:updated>2022-03-28T14:50:35.541Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*UsvXL4A1FO2vG-499dFHpQ.png" /></figure><p>Historically, the dialogue surrounding the production and sale of cannabis has been heated and divisive. Supporters of legalization often tout its perceived health benefits while opponents claim that it hurts people and society. Regardless, states move forward by continuing to lift restrictions on the sale of cannabis and the federal government begins to discuss regulating and <a href="https://www.nytimes.com/2021/07/14/us/politics/marijuana-legalization-schumer.html">taxing it</a>. In 2020 alone, legal sales of cannabis increased by <a href="https://www.forbes.com/sites/willyakowicz/2021/03/03/us-cannabis-sales-hit-record-175-billion-as-americans-consume-more-marijuana-than-ever-before/?sh=26248a582bcf">46%</a>, highlighting the increasing demand for this emerging industry.</p><p>The breadth of scientific literature studying the physiological and psychological health effects of cannabis is largely focused on compounds called cannabinoids. These compounds bind to cannabinoid receptors (referred to as <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120766/">CB1 and CB2</a>) in the brain and throughout the body. The most common cannabinoids are Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). Although the <a href="https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd">FDA </a>has only approved one cannabis-derived drug product, <a href="https://www.epidiolex.com/">Epidiolex</a> (CBD), for the treatment of seizures associated with tuberous sclerosis complex, there are a variety of other therapeutic applications of cannabinoids in clinical trials such as: acting as antiemetics for adults with chemotherapy-induced nausea and vomiting, reducing pain for adults with chronic pain, and improving spasticity symptoms in adults with multiple sclerosis.</p><p>The mechanisms by which cannabinoids interact with the body is still being studied, highlighting the necessity for efficient means of production. However, we can get a better understanding of these processes by taking a look at the central nervous system. As mentioned before, humans have cannabinoid receptors, CB1 and CB2. CB1 receptors are primarily localized in neurons and CB2 receptors are expressed in the immune system. These receptors are present in humans because we naturally produce cannabinoids within our own bodies, known as endocannabinoids (whereas “phytocannabinoids” are found in the cannabis plant). The activation of CB1 receptors, for example, results in the inhibition of synaptic transmission which alters the signaling pathways within the brain. Endo-cannabinoid signaling pathways have been shown to be involved in the pathophysiology of epilepsy, and drugs such as Epidiolex can target these pathways for therapeutic purposes</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*3jQOh1WjRLAb7kmaHHYqjw.png" /></figure><p>Despite the potential for therapeutic uses of cannabinoids, traditional means of farming cannabis has significant environmental impacts. Commercially produced cannabis has been shown to contribute to forest fragmentation, soil erosion, and <a href="https://www.sciencedaily.com/releases/2017/10/171031202705.htm">landslides</a>. Additionally, cannabis emits volatile organic compounds (VOCs) called terpenes that are extremely reactive in the atmosphere and produce ozone-degrading <a href="https://daily.jstor.org/the-environmental-downside-of-cannabis-cultivation/">aerosols</a>. Lastly, cannabis cultivation has a huge electricity demand, prompting more state regulations on this emerging <a href="https://energynews.us/2019/06/27/most-states-legalizing-marijuana-have-yet-to-grapple-with-energy-demand/">industry</a>. An alternative and perhaps more environmentally friendly means of producing CBD and THC is through metabolic engineering.</p><p>Picture an organic chemist synthesizing compounds for pharmaceutical use in a laboratory setting. A variety of reagents, glassware, expensive analytical instruments, and years of expertise are required. At the industrial level, this process can be sped up in manufacturing facilities to produce compounds in large-scale quantities.</p><p>Now picture this process automated at the cellular level. The cells that make up single-cell organisms, plants, and animals (yes, even you) are constantly producing new compounds through a variety of reactions, almost acting as miniature factories. If we follow the familiar reaction of yeast fermentation, used to produce your favorite beer at a local brewery, we can see how cellular metabolism can be a useful tool for the production of chemical compounds. In large vats, breweries typically mix sugary media that allows yeast to undergo fermentation, the process by which yeast extract energy from carbohydrates. The particular strain of yeast used in breweries produces ethanol (alcohol) and carbon dioxide (bubbles) during fermentation.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*yEgUjnej5tGM81cVctSFOw.png" /><figcaption>The process of fermentation, used in making alcohol and cannabinoids</figcaption></figure><p>Metabolic engineering can take advantage of processes such as yeast fermentation by modifying the metabolism processes of yeast to produce cannabinoids (instead of, or in addition to alcohol) during fermentation. In a recent groundbreaking <a href="https://www.nature.com/articles/s41586-019-0978-9">study</a> (2019) done by researchers at Berkeley, the metabolic pathway of yeast to produce cannabinoid precursors was laid out, presenting a clearer platform for the cannabinoid production.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*s0_jIl-aWimQAdZDdaUoSg.png" /><figcaption>The chemical process of cannabinoid metabolic engineering</figcaption></figure><p>There are over 100 cannabinoids that are found in cannabis, but scientists usually only study CBD and THC. These cannabinoids are abundant in cannabis, which makes them easy to study. However, the other 100 are not as robustly studied because they are more difficult to isolate and require more plant biomass to extract them. These rare cannabinoids have potential applications that we are currently unable to probe. With metabolic engineering, it is possible to engineer cells to produce these rare cannabinoids efficiently and scale-up using different fermentation processes.</p><p>A handful of companies have already started to implement metabolic engineering to produce cannabinoids. <a href="https://demetrix.com/">Demetrix</a> and <a href="https://hyasynthbio.com/">Hyacynth</a> are two new companies that have begun engineering yeast strains to produce cannabinoids using the fermentation process discussed earlier. These companies modify the metabolic pathway of yeast to convert sugar into compounds that can then be converted using enzymes to make THC and CBD.</p><p>In addition to using yeast as production platforms for cannabinoids, other microbes have also been suggested. <a href="https://www.farmako.de/en/">Farmako</a>, a German biotech company, uses bacteria instead of yeast to produce rare cannabinoids. Bacteria are useful because the cannabinoids are naturally separated from the bacteria whereas in a yeast-system, the cannabinoids have to be separated from the yeast in a second <a href="https://synbiobeta.com/wp-content/uploads/2019/07/Cannabinoid-Fermentation-SynBioBeta-Industry-Report-June-2019-v2.pdf">step</a>. In 900 hours, Farmako has reported that 4.5 kg of THC are produced per 1 g of bacterial mass. <a href="https://renewbiopharma.com/">Renew Biopharma</a>, a company that develops therapeutics for neuroinflammatory diseases, has started using microalgae as a production host for cannabinoids.</p><p>The field of metabolic engineering continues to grow, and numerous companies have taken interest in using this technology as a tool to efficiently produce compounds such as cannabinoids. Using the fermentation processes discussed here, producing cannabinoids can be more sustainable and affordable than traditional cannabis cultivation. In the future, you might even imagine recreational CBD and THC breweries as social hubs. Greater yields of cannabinoids, without the need for large volumes of plant biomass, will allow scientists to take a deeper dive into their biological mechanisms and better understand what is appearing to be a useful tool.</p><p><strong>Written by Katie Kloska, Associate &amp; PhD Candidate</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c5c7490a080c" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Meat Without Animals: Exploring Public Policy Around Food Made with Cultured Animal Cells” —…]]></title>
            <link>https://admin-21183.medium.com/meat-without-animals-exploring-public-policy-around-food-made-with-cultured-animal-cells-3d9776a9f077?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/3d9776a9f077</guid>
            <category><![CDATA[sustainability]]></category>
            <category><![CDATA[biotechnology]]></category>
            <category><![CDATA[cultured-meat]]></category>
            <category><![CDATA[public-policy]]></category>
            <category><![CDATA[cellular-agriculture]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Wed, 22 Sep 2021 14:44:23 GMT</pubDate>
            <atom:updated>2021-09-22T14:44:23.908Z</atom:updated>
            <content:encoded><![CDATA[<h3>Meat Without Animals: Exploring Public Policy Around Food Made with Cultured Animal Cells” — Commentary and Conversation on the CFA’s Latest Panel</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*RkEhlSyuRyBq0nqVebIVVQ.jpeg" /></figure><p>Watching the debate between Jessica Almy, Isha Datar, Tom Neltner, and Jim Thomas at the Consumer Federation of America “Meat Without Animals: Exploring Public Policy Around Food Made with Cultured Cells” was unlike any other panel I had tuned into in the space of cellular agriculture. I am likely to find discussions where all panelists agree that cell ag is a step forward as a solution to climate change, food security, and our faltering food system, if not a completely revolutionary idea. While discussions like these stoke complex ideas around regulatory challenges, sustainability, biotechnology, and what we eat, they rarely represent a dynamic debate. Bringing two sides into a direct conversation was an efficient way to move the conversation forward. In a boiled down version, the debate was this: that cell based protein is a key way in which we transform a food system that leaches our climate and feeds our world, or it is just another sector of “big meat” monopolies including Tyson and Purdue, that leaves a minimal impact on climate and food security, and hurts small farmers. Will cellular agriculture just become another small subsection of an oligopolistic market, one that remains too small to create a true environmental impact?</p><p>Tom Philpott of publication <em>Mother Jones</em> moderated the panel of higher ups from the Good Food Institute, New Harvest, the ETC Group, and the Environmental Defense Fund. He began with the sentiment that while meat production may not change for climate change, climate change is coming for our protein industry. This is true — from ocean acidification to forest fires and water shortages, conventional protein production will experience major stressors. Philpott then raised the question of funding, a continuously broached subject in the field due to the imbalance of growing private and waning public investment. Who should fund research into cellular agriculture? Should the public sector? Should it be the FDA? The USDA? We’ve seen governments such as New Zealand’s and Singapore’s <a href="https://www.nature.com/articles/d41586-020-03448-1">fund grants</a> into research behind cell cultivated proteins. The first cell cultivated hamburger in 2013 out of the Netherlands came from a federal grant. Of course, there is exponentially more private money available than public in this space; however, funding academic research and subsidizing the alternative protein market would accelerate it’s progress and maintain long term success (as there would be more open access research and a safety net for the industry). If we want this market to be anything besides a niche subsection of the industrialized meat market, we need the public sector’s support. Small startups and VC backed companies have a largely significant place in the chain of innovation, but scale up requires federal interest and the implementation and advocacy of targeted policy.</p><p>Almy, head of policy at the Good Food Institute, pointed to everyday environments of families around the country as a strong influence. These families, despite what intentions are present, are “overwhelmingly influenced by their food environment, and the options that are made available to them.” Almy cited the GFI’s main concerns of antibiotic resistance and climate change, saying that cellular agriculture is certainly a viable solution to these looming and current challenges. Almy was careful to say that we need to give consumers choices. Choices that will ensure a sustainable future and reduce the externalities of industrial meat. Language is critical when discussing the nascent field; as we have seen with recent public health crises, our country can quickly divide itself over feeling as though we have choices compared to a directive. I also believe that cellular agriculture is not an and/or situation in relation to industrial agriculture, but an and/and one. We do not have the resources or the public backing to eliminate traditional or industrial farming, but we have the power to reduce it. We have the power to implement regenerative practices, in addition to cell cultivated products entering the market.</p><p>Thomas, co-executive director and researcher for the ETC Group, respectfully countered Almy’s view. He acknowledged the “very real” crises of climate change, antibiotic resistance, and food security, but countered that cellular agriculture is not the solution. As an approach, Thomas believes cellular agriculture is “buckling down on the wrong food system.” He cited large and problematic corporations as a serious threat to cellular agriculture’s success, which he believes is not encompassed by a “moonshot” approach to culturing cells in a petri dish. He believes in an “earthshot,” which expands on what our Earth already has to offer, and which favors Indigenous peoples and small farmers. This view is idyllic, and it seems to be one of retrospective pastoralism. Although we need to support small farmers and regenerative agriculture, we also need to acknowledge the role innovative (and big) industry plays in feeding our steadily growing population and ensuring multiple communities have access to protein through distribution. Certainly, privately funded moonshot projects encourage participation in the field, but it is true that they will not succeed without policy and continuous R&amp;D backing on the other end. It is not misplaced to worry that large corporations may monopolize the field (as it is our primary system of food distribution), but it already exists as an institution that would take a major overhaul to change in favor of Thomas’s view. Both Thomas and Isha Datar of New Harvest took a wider stance, bringing related policy into the conversation. While these are not directly related to policy around efficiently producing protein, they do have implications for what will happen with the land that would no longer be used for industrial farming. These questions ranged from: how will we ensure Indigenous land is restored while incorporating this new technology? How will we bring regenerative agriculture hand in hand with high tech food? All the panelists acknowledged that we live in a capitalistic system that does not know other ways of operating on a mass scale. However, at the moment these are only tangentially related policies that need to be addressed after market success. We need specific policy that first pushes regulation and ensures the market is subsidized. Thomas also brought up the food sovereignty movement, the small farmer, and a report the ETC Group recently published titled “The Long Food Movement,” that looks 25 years into the future, and takes an analytical approach to agribusiness movements like cellular agriculture.</p><p>Neltner of the Environmental Defense Fund took a midline approach, saying cellular agriculture would likely be part of the solution, but admitted he wasn’t sure when this would be achievable. He brought up the point that the industry should learn from past mistakes of others, such as the dialogue around GMOs. While the panel did not touch on this further, this is a significant point. Cell Agri has <a href="https://medium.com/cellagri/cellular-agriculture-and-the-monsanto-lesson-a18aa6c29e0">written</a> on the topic, warning the industry to learn from the “Monsanto lesson.” The national conversation that was started around GMOs, one that often inspires <a href="https://www.washingtonpost.com/news/wonk/wp/2015/07/06/why-people-are-so-scared-of-gmos-according-to-someone-who-has-studied-the-fear-since-the-start/">misplaced fear</a>, was spurred by the infamous controversies around Monsanto seeds, lawsuits, and the company’s history concerning Agent Orange, used in the Vietnam war. At Helikon, we believe language and public education are critical to passing policy and increasing consumer acceptance in this field. Cultivated protein is <a href="https://labgrownmeat.com/gmo-lab-grown-meat/">not always</a> a GMO, yet it’s likely that many will believe it is by default. Just as the general public often misunderstands the science behind GMOs, the science behind cultivated meat is likely to be heavily questioned. We have seen the mRNA vaccine for Covid-19 causing concern around the health of our bodies and of our genetic makeup. How will we strive to create an accurate dialogue around cultured cells?</p><p>Datar of New Harvest said during the discussion that reduced land use was one of the aspects of cellular agriculture that excited her most. “Right now we dedicate 27 percent of land on this planet towards farming and animals for food.” Datar went on to point out that cellular agriculture could reduce this land use by 90 percent, or 50 percent if a less optimistic stance is taken. Rewilding the lands, restoring topsoil, and regenerative agriculture were also on Datar’s mind. “None of that will happen unless there’s appropriate policy that makes room for regenerative agriculture, Indigenous land management, and so on.” She finished her opening statement by referencing the disruptive nature of cellular agriculture, saying that it has the “power to bring about systemic change.”</p><p>Datar later told Helikon, “To me, the debate felt like one of the first I’ve seen that evaluated cellular agriculture against other types of radical agricultural policy, rather than the status quo — which obviously everyone agrees needs to change. We all recognized that it isn’t simply a technological silver bullet — that for it to truly have the positive impact that is being promised, there needs to be a ripple effect of change across policy, the supply chain, worker’s rights, and more.” She continued, “I loved the comment by Jim — that the one thing cell ag could do to be part of the broader solution is to “LISTEN.” It is true. Cell ag proponents could do better to be more in tune with the broader movement moving away from industrial animal ag.”</p><p>Almy had similar thoughts, telling Helikon, “Good food needs to be affordable, accessible, and delicious…And there’s clearly a role for policy to play in making it happen. (USDA took a <a href="https://www.federalregister.gov/documents/2021/09/03/2021-19057/labeling-of-meat-or-poultry-products-comprised-of-or-containing-cultured-animal-cells">step forward</a> on that [recently].) And both the executive and legislative branches need to prioritize investments into public research that can benefit the sector as a whole by addressing white spaces and bringing costs down. What the United States and other governments around the world do now will impact not only the choices that consumers have available to them, but also our food supply’s contribution to the climate crisis, antimicrobial resistance, and zoonotic diseases. The stakes could not be higher.”</p><p>The alternative protein market has been booming for the last 5 years, with <a href="https://www.fooddive.com/news/31b-invested-in-alternative-proteins-in-2020-report-says/596993/">$3.1 billion</a> invested in 2020. We need various sustainable options to feed what will be a population of 9 billion by 2050. This will not be a one system solution, and the time to innovate the various ways in which we will feed ourselves is now. Key drivers of success include consumer acceptance, regulatory policy, and scale up (which will need a secure supply chain established, perhaps in the form of more <a href="https://www.helikonconsulting.com/blog/state-of-the-industry-business-to-business-marketing-model-could-strengthen-cellular-agriculture-scalability-amp-investing-in-ingredients">B2B</a> interactions). While there is not an established timeline for when all of these products may hit market, there is already significant indication that they <a href="https://www.bloomberg.com/news/articles/2021-09-20/eat-just-raises-97-million-more-to-fund-cultured-meat-production?sref=taxRtTxi">will</a>. In a similar stance to Helikon’s “and/and” notion of cultivated meat coupling with regenerative agriculture, Almy continued, “At GFI, we’ve been thinking about how alternative proteins (including cultivated meat) and regenerative agriculture can be complementary strategies to feed 10 billion by 2050 without exceeding our planetary boundaries. I’m looking forward to more open and spirited exchanges like it.”</p><p>Written by Thea Burke, Helikon Consulting</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3d9776a9f077" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[A Brand New Beer: The Implications of GMO Yeast]]></title>
            <link>https://admin-21183.medium.com/a-brand-new-beer-the-implications-of-gmo-yeast-8b34b60b5979?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/8b34b60b5979</guid>
            <category><![CDATA[microbrewing]]></category>
            <category><![CDATA[gmo-yeast]]></category>
            <category><![CDATA[genetic-engineering]]></category>
            <category><![CDATA[brewers]]></category>
            <category><![CDATA[beernews]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Wed, 25 Aug 2021 15:19:15 GMT</pubDate>
            <atom:updated>2021-08-25T15:19:15.371Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*wySZuTeBn-GdTFZCjYf3VQ.jpeg" /></figure><p>Beer is America’s favorite alcohol, with 42% of drinkers stating that they prefer beer to wine (34%)1. In its oldest form, beer can be traced back multiple millennia and in its many variations have been popular throughout recorded history. The beers most of us are familiar with today likely contain the following ingredients: water, malt, hops and yeast. Beer is created by first making wort, a sweet starch water made by mixing hot water and a starch source such as malted barley. Wort is then boiled down to concentrate its sugars and hops are added to imbue the liquid with bitterness, flavors, and aromas. Yeast is finally added to the hopped wort for fermentation where it converts sugars into ethanol and carbon dioxide.</p><p>As a society we have become more environmentally conscious. This has led us to think about the impact of our personal choices on the world at large, including our beverage choices. A recent study out of the University of Michigan found that the upstream emissions of beer in the state of Oregon were equal to 202,700 metric tons of carbon dioxide, which is comparable to running 42,800 passenger vehicles for a year2. The largest contributors were packaging, refrigeration, and raw material production. Within raw material production malted barley production required the most energy, with hops contributing very little. This review utilizes a study conducted by the Climate Conservancy that specifically studied the life cycle assessment of <a href="https://www.ess.uci.edu/~sjdavis/pubs/Fat_Tire_2008.pdf">New Belgium’s Fat Tire Amber Ale</a>. However, this amber ale is not a “hoppy” beer and requires 20 times less hops than common craft brews3. Hop-forward beers have become so popular that the demand for hoppy IPAs has increased 10 times in craft beer industry in the past 10 years4, making the question of sustainable hop production an important topic. Hop production for brewing is energy intensive. Emissions come from use of agricultural machinery, irrigation, fertilizer use and associated nitrous oxide release, and kilning. In addition to the environmental impact of hop production, the changing climate poses a threat to hop production. Germany and the US are the world’s largest hop producers contributing to 2/3 of global production. In recent years droughts have caused reduced yields and altered compositions of hops in both Europe and the Pacific Northwest region of US6, where most domestic hop production occurs.</p><p>One strategy that provides a novel solution to this problem is use of genetically modified yeast that can impart a hoppy flavor to beer without the addition of hops through the addition of terpenes. Terpenes are a class of aromatic compounds that contribute to the aroma and flavor of plants, vegetables, and flowers, including hops. Two monoterpenes, linalool and geraniol, have been identified as key molecules responsible for hoppy-ness. Researchers at UC Berkely’s Keasling lab led by then graduate student Charles Denby were successful in identifying yeast-active linalool and geraniol synthases and engineering brewer’s yeast strains that expressed them, thereby creating yeast strains that were capable of imparting the flavor and aroma of hops7.</p><p><a href="https://berkeleyyeast.com/">Berkeley Yeast</a>, the company founded by Dr. Denby, sells and custom makes yeast strains for beer and wine production. Several breweries have brought these beers to market. <a href="https://drinkdrakes.com/">Drake’s Brewing</a> founded in San Leandro, California has utilized the High Sierra yeast strain, which contain terpene producing genes, in two of their now retired beers. Weird Science, a pale ale, and Steroid Era, a brut IPA, both feature Berkeley Yeast’s genetically modified yeast strain8, 9. <a href="https://www.lallemandbrewing.com/en/canada/">Lallemand Brewing</a>, one of the largest distributors of brewing yeast, have also created a new genetically engineered yeast strain called Sourvisiae®10. This strain features the addition of the lactate dehydrogenase gene which allows brewers to simultaneously ferment and sour beer instead of the traditional two-step process required to create sours. Rhinegeist, a Cincinnati based brewery, uses the Sourvisiae® for all of its sour beers11.</p><p>In addition to adding genes, genetic engineering of yeast has allowed brewers to fine tune production through removal of unwanted characteristics such as off flavors or dry mouthfeel. Normally during the fermentation step brewer’s yeast converts fermentable sugars such as glucose, fructose, maltose, and maltotriose into ethanol and carbon dioxide. This process leaves behind non-fermentable complex carbohydrates (starch and dextrins). However, brewer’s yeast strains that contain the STA-1 gene, which encodes a glucoamylase enzyme, can break down these complex carbohydrates into fermentable sugars. These yeast strains are termed diastatic and are able to continue fermentation beyond what is desirable, or even after packaging. Starches and dextrins contribute to the body of beer. Over-fermented beer from diastatic strain contamination have a drier mouthfeel, clove-like off flavor, and carry the risk of post-packaging explosions12.</p><p><em>Saccharomyces trois</em>, a yeast strain known for producing tropical notes such as mango and pineapple in its finished product, contains this STA-1 gene. Berkeley Yeast have created a new yeast strain using genetic engineering that has all of the characteristics of its parent strain <em>Saccharomyces trois</em>, except for the STA-1 gene13. Thus allowing brewers to take advantage of the positive characteristics without the drawbacks of using a diastatic strain. <a href="https://fieldworkbrewing.com/">Fieldwork Brewing</a> has utilized this non-diastatic strain for their fruity double IPA Loser’s Club Vol. VII14.</p><p>As with most technological innovations that threaten the status quo, there has been push back from brewers who prefer the traditional methodology. Brewers such as Matthew Brynildson from <a href="https://www.firestonebeer.com/">Firestone Walker Brewing Co.</a> worry that using genetically engineered yeast strains would open up doors to a future where beer can be made “with water, a drum of the cheapest sugar source you can find, and yeast that makes all the flavors that we used to get from barley and hops”15. Others find that these innovations will allow brewers to be more creative, sustainable, and produce beer that suffers less from batch-to-batch variability. Regardless of where brewers stand on the use of GMO yeast, the changing climate and consumer demand for a more sustainable future are likely to dictate the future of beer production.</p><p>References</p><p>1. Dugan A. Americans Still Favor Beer Over Other Alcoholic Beverages.<a href="https://news.gallup.com/poll/238100/americans-favor-beer-alcoholic-beverages.aspx"> https://news.gallup.com/poll/238100/americans-favor-beer-alcoholic-beverages.aspx</a></p><p>2. Heller M. Food Product Environmental Footprint Literature Summary: Beer. State of Oregon Department of Environmental Quality.<a href="https://www.oregon.gov/deq/FilterDocs/PEF-Beer-FullReport.pdf"> https://www.oregon.gov/deq/FilterDocs/PEF-Beer-FullReport.pdf</a></p><p>3. Shellhammer DGHaTH. An Overview of Sustainability Challenges in Beer Production, and the Carbon Footprint of Hops Production. 2019;doi:10.1094/TQ-56–4–0731–01</p><p>4. Shellhammer SRLaTH. How Hoppy Beer Production Has Redefined Hop Quality and a Discussion of Agricultural and Processing Strategies to Promote It. 2019;doi:10.1094/TQ-56–1–0221–01</p><p>5. Potopová V, Lhotka O, Možný M, Musiolková M. Vulnerability of hop-yields due to compound drought and heat events over European key-hop regions. <em>International Journal of Climatology</em>. 2021;41(S1):E2136-E2158. doi:<a href="https://doi.org/10.1002/joc.6836">https://doi.org/10.1002/joc.6836</a></p><p>6. Kennedy C. Climate &amp; Beer. National Oceanic and Atmospheric Administration.<a href="https://www.climate.gov/news-features/climate-and/climate-beer"> https://www.climate.gov/news-features/climate-and/climate-beer</a></p><p>7. Denby CM, Li RA, Vu VT, et al. Industrial brewing yeast engineered for the production of primary flavor determinants in hopped beer. <em>Nature communications</em>. Mar 20 2018;9(1):965. doi:10.1038/s41467–018–03293-x</p><p>8. Weird Science. Drake Brewing.<a href="https://drinkdrakes.com/beers/weird-science/"> https://drinkdrakes.com/beers/weird-science/</a></p><p>9. Steroid Era. Drake Brewing.<a href="https://drinkdrakes.com/beers/steroid-era/"> https://drinkdrakes.com/beers/steroid-era/</a></p><p>10. Sourvisiae. Lallemand Brewing.<a href="https://www.lallemandbrewing.com/en/united-states/product-details/sourvisiae/"> https://www.lallemandbrewing.com/en/united-states/product-details/sourvisiae/</a></p><p>11. Garrett J. Yeast of Eden — Why Genetically Modified Yeast Could Be the Next Step in Beer’s Evolution.<a href="https://www.goodbeerhunting.com/blog/2020/1/13/yeast-of-eden-why-gmo-yeast-could-be-the-next-step-in-beers-evolution"> https://www.goodbeerhunting.com/blog/2020/1/13/yeast-of-eden-why-gmo-yeast-could-be-the-next-step-in-beers-evolution</a></p><p>12. Krogerus K, Gibson B. A re-evaluation of diastatic Saccharomyces cerevisiae strains and their role in brewing. <em>Applied microbiology and biotechnology</em>. May 2020;104(9):3745–3756. doi:10.1007/s00253–020–10531–0</p><p>13. Alexandre Trois. Berkeley Yeast.<a href="https://berkeleyyeast.com/beerstrains/p/alexandretrois"> https://berkeleyyeast.com/beerstrains/p/alexandretrois</a></p><p>14. Loser’s Club Vol. VII. Fieldwork Brewing.<a href="https://fieldworkbrewing.com/beer/losers-club-vol-vii/"> https://fieldworkbrewing.com/beer/losers-club-vol-vii/</a></p><p>15. Bland A. GMO Yeast Mimics Flavors Of Hops, But Will Craft Brewers Bite?<a href="https://www.npr.org/sections/thesalt/2018/04/04/599147983/gmo-yeast-mimics-flavors-of-hops-but-will-craft-brewers-bite"> https://www.npr.org/sections/thesalt/2018/04/04/599147983/gmo-yeast-mimics-flavors-of-hops-but-will-craft-brewers-bite</a></p><p>Written by Kana Hamada, Associate for Helikon Consulting</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8b34b60b5979" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Plant Based and Mediterranean Diets Strengthen Microbiome and Create Protection Against Heart…]]></title>
            <link>https://admin-21183.medium.com/plant-based-and-mediterranean-diets-strengthen-microbiome-and-create-protection-against-heart-a927d74b9f72?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/a927d74b9f72</guid>
            <category><![CDATA[plant-based-diets]]></category>
            <category><![CDATA[alternative-protein]]></category>
            <category><![CDATA[heart-disease]]></category>
            <category><![CDATA[mediterranean-diet]]></category>
            <category><![CDATA[microbiome]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Thu, 19 Aug 2021 15:26:20 GMT</pubDate>
            <atom:updated>2021-08-19T15:26:20.366Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Plant Based and Mediterranean Diets Strengthen Microbiome and Create Protection Against Heart Disease: A Stanford Study</strong></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*P4kBrT5N-7FvB0Og8YhVcQ.jpeg" /></figure><p>2018), consumption of which has been associated with increased risk of weight gain, obesity, and associated non-communicable diseases such as type 2 diabetes (Srour et al. 2020). Additionally, they tend to be as high as red meat in sodium and saturated fat. NOVA is a system that classifies food products according to how they’ve been processed, whether that’s biologically, physically, or chemically.</p><p><strong>Could plant-based meat alternatives decrease cardiovascular risk?</strong></p><p>In 2020, the Sonnenburg Lab and Gardner Lab, both out of Stanford University collaborated on this exact question. They performed a randomized crossover trial, named ​​<a href="https://academic.oup.com/ajcn/article/112/5/1188/5890315?login=true">SWAP-MEAT</a> (The Study With Appetizing Plantfood — Meat Eating Alternatives Trial). In the trial, 36 participants were randomized into one of two groups. The first group was directed to consume two or more servings of red meat a day for eight weeks total (referred to as the ‘Animal phase’), limiting the amount of other meats like fish or white meat. After eight weeks, this group was directed to switch to consuming the same serving size of plant-based meat (provided by Beyond Meat) for an additional eight weeks, and referred to as the ‘Plant phase’. The second group did the opposite, starting with the Plant phase, and switching to the Animal phase after eight weeks. All participants had to keep a strict log of their dietary habits, and fasting blood samples were collected from each participant every two weeks.</p><p><strong>Plant-based meat alternatives do not increase TMAO levels</strong></p><p>Participants were able to maintain their selected diets for the entirety of the sixteen weeks, consuming comparable amounts of animal derived meat to plant-based meats. As expected, sodium, saturated fats, and protein intake was about the same at both phases, while fiber intake decreased during the Animal phase compared to the Plant phase, given Beyond Beef products contain added dietary fiber. In addition, low-density lipoprotein (LDL) cholesterol (commonly referred to as “bad” cholesterol) and weight of participants were significantly lower following the Plant phase when compared to the Animal phase. As might have been hypothesized, TMAO, our cardiovascular risk marker, was significantly lower in the Plant phase compared to the Animal phase. Of special note, however, the order in which participants completed the Plant or Animal phase mattered to their TMAO levels. The first group, assigned to the Animal phase first, showed a decrease in mean TMAO following the switch to Plant phase. The second group would be expected to show the opposite effect: an increase in mean TMAO following transition from the Plant phase to the Animal phase. However, what the researchers observed was no change in mean TMAO. They interpreted these results as a potential microbiome effect — the Plant phase adapted microbiome may provide a protective effect against TMA production (and thus TMAO production).</p><p><strong>What does this mean for meat alternatives?</strong></p><p>While this study was small, the significant difference in TMAO is promising when it comes to making dietary recommendations to decrease cardiovascular risk markers. Not only would a shift away from red meat consumption to plant-based meat provide benefits to individual health, but plant-based options offer an environmentally sustainable option. On the other hand, while LDL cholesterol and weight also decreased in participants during the plant-based meat alternative phase, the health impact of ultra-processed foods should not be dismissed, as this study only monitored for cardiovascular risk. There are two potential solutions to striking a balance between decreased cardiovascular risk and limiting ultra-processed food consumption. First, one way of interpreting this study is that not eating meat allows for the gut microbiome to protect against TMAO production, and occasional meat consumption might be just as cardiovascularly healthy as no meat consumption. From a sustainability standpoint, while decreasing meat consumption is key, removing meat as a dietary option would be best. Another solution may be driven by cellular agriculture. Could lab grown meat be made without TMAO precursors? The future could hold meat created without ultra-processed ingredients, while satisfying the perfect balance of cardiovascular health and environmental sustainability.</p><p><strong>References</strong></p><p>Crimarco, Anthony, et al. “A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood — Meat Eating Alternative Trial (SWAP-MEAT).” <em>The American journal of clinical nutrition</em> 112.5 (2020): 1188–1199.</p><p>Janeiro, Manuel H., et al. “Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target.” <em>Nutrients</em> 10.10 (2018): 1398.</p><p>Koeth RA, Lam-Galvez BR, Kirsop J, Wang Z, Levison BS, Gu X, Copeland MF, Bartlett D, Cody DB, Dai HJ, et al. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. J Clin Invest 2018;129(1):373–87.</p><p>Monteiro, Carlos Augusto, et al. “The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing.” <em>Public health nutrition</em> 21.1 (2018): 5–17.</p><p>Srour, Bernard, et al. “Ultraprocessed food consumption and risk of type 2 diabetes among participants of the NutriNet-Santé prospective cohort.” <em>JAMA internal medicine</em> 180.2 (2020): 283–291.</p><p>Tang, WH Wilson, et al. “Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.” <em>New England Journal of Medicine</em> 368.17 (2013): 1575–1584.</p><p>Tang, WH Wilson, et al. “Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.” <em>Circulation research</em> 116.3 (2015): 448–455.</p><p>Tilg, Herbert. “A gut feeling about thrombosis.” <em>New England Journal of Medicine</em> 374.25 (2016): 2494–2496.</p><p>Wang, Zeneng, et al. “Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women.” <em>European heart journal</em> 40.7 (2019): 583–594.</p><p>Written for Helikon by Elisa Caffrey, Guest Author and Stanford PhD Candidate</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a927d74b9f72" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Regulation in the Cosmetics Industry: Controlling our Diet for Food-Based Cosmetics]]></title>
            <link>https://admin-21183.medium.com/regulation-in-the-cosmetics-industry-c0561f7eefae?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/c0561f7eefae</guid>
            <category><![CDATA[cosmetics]]></category>
            <category><![CDATA[cosmetic-regulatory]]></category>
            <category><![CDATA[personal-care-products]]></category>
            <category><![CDATA[cosmetic-industry]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Mon, 26 Jul 2021 19:51:28 GMT</pubDate>
            <atom:updated>2021-07-29T17:34:27.133Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*6h6ksL51k8K3LWNZ15MxeQ.jpeg" /></figure><p>You are what you eat, or in the case for “clean” cosmetics, you are what you put on your body. But the original saying might still be apt, as more and more it seems like “superfoods’’ and naturally-derived ingredients have become a key selling point for beauty products and brands, especially from newer, smaller companies looking to compete with big beauty brands. Amongst Lush’s bestsellers, you’ll find shower gels infused with rose, lemon, and vanilla and bath bombs infused with lemongrass, avocado, and extra virgin olive oil. Gwyneth Paltrow has even gone so far as to eat fries dipped in her skincare company Goop’s skin cream to show that her beauty products are made with only food-grade ingredients. “Clean” cosmetics clearly have a big and growing audience. On major beauty retailer Sephora’s skincare bestsellers page, there’s an award-winning cleanser packed with kale, spinach, and green tea and a lip mask packed with an assortment of berries.</p><p>— -</p><p>However, just as loosely as “organic” crops are associated with health and sustainability, the benefits of these “natural” ingredients in cosmetics for our health and the planet’s health have thus far lacked any scientific backing. Unlike with food and agriculture, there is little to no regulation on the cosmetics industry; marketing is not regulated by the Federal Trade Commission nor is safety regulated by the Food and Drug Administration beyond the approximately 30 chemicals it has banned from being used in beauty products — a meager number compared to the more than 1,300 chemicals banned in the European Union. The nonprofit Environmental Working Group has tried to step in as a watchdog on the safety and efficacy front, pooling information on chemicals from toxicity and regulatory databases and providing ratings from 1 to 10, with 10 corresponding to ingredients with the greatest concern. I took a look at the list of 75 ingredients that Briogeo, a hair care company, uses in its products and found that only ten had a score of 1, while two had a score above 5 and 49 had a score of 0, meaning there was limited data available on its safety. Furthermore, in their best-selling product, <strong>Don’t Despair, Repair!™</strong>, only one of those ingredients with an EWG score of 1 even shows up in the first ten ingredients listed — ingredients are listed in order of predominance, with the ingredients used in the greatest amount first. Altogether, that makes it hard for me to take Briogeo’s word that their “clean care” and “healthy hair” promises also guarantee our personal well-being. But many critiques can be made about EWG scores, including the fact that lack of data on a chemical doesn’t equate it to poison, and an EWG score of 1 or 10 doesn’t automatically mean that an ingredient is safe or toxic, respectively, because the “dose makes the poison,” for both synthetic and natural ingredients.</p><p>Surprisingly, with the rise of consumer demand for “natural” and “safe” products, Vox reported that big beauty companies that are being forced to reformulate products have been trying to lobby the federal government for more funding and regulatory power to the FDA to test and oversee chemical safety and usage in cosmetics. They argue, and rightly so in some cases, that synthetic chemicals can be just as safe — at the right dosage, that is — and efficacious as their natural counterparts. That kale packed in the Superfood Cleanser I mentioned earlier, it definitely wasn’t just blended and strained. The most common extraction method for <em>Brassica oleracea acephala</em>, the antioxidant on the product’s ingredient list, from kale is in boiling aqueous methanol, which can pose hazardous working conditions due to methanol toxicity.</p><p>— -</p><p>In the cosmetic industry’s rapid race to reinvent products with natural formulations, less attention has been paid to make transparent the environmental impacts of these products and new supply chains, from the sourcing of raw materials to their processing and the control of emissions and waste. One major highlight on sustainability that I found was Lush’s journey to remove and replace palm oil from their products. Granted, these strides by Lush were only taken after they received heavy push back by the public, and they have yet to remove it entirely from their products. They provide a great article explaining why palm oil is unsustainable, mentioning that while there are examples out there of good growing practices that incorporate palm, industrialization of the crop has led to massive deforestation and human rights abuses. Even “sustainable palm oil,” as certified by the Roundtable on Sustainable Palm Oil, is rife with controversy, as producers and processors can become RSPO members without having their operations accredited.</p><p>Remember Briogeo’s <strong>Don’t Despair, Repair!™</strong> product I mentioned earlier? I tried to look up information on the environmental impacts of sourcing 1,3-propanediol from corn, the fifth ingredient on its list and the first with an EWG score of 1, and happily stumbled upon the <a href="https://ec.europa.eu/environment/pubs/factsheets.htm">European Commission’s page of environmental factsheets</a>. For 1,3-propanediol, it provides a life cycle assessment, pointing out the environmental impacts associated with all stages of the chemical’s life: an environmental assessment, supplying numbers for its impact on things like climate change, ecotoxicity, land use, and a chart illustrating production chains (from both synthetic and natural sources). But the factsheets do leave much to be desired for a true comparison to determine what source of 1,3-propanediol is the most renewable. Here again is where funding for and intervention by a regulatory body to rigorously test chemicals and hold companies accountable in the US would benefit consumers and our planet, and even corporations (though possibly to the detriment of small businesses that have arisen from the “clean” cosmetics demand).</p><p>— -</p><p>For consumers increasingly concerned with safety and sustainability, the rise of cosmetics made from more natural and renewable sources reflects their power and influence. Now, it might be time for consumers to put that same pressure on the federal government. Several bipartisan proposals have been drafted by Congress, some even, like the <a href="https://www.govtrack.us/congress/bills/116/s726">Personal Care Products Safety Act</a>, since 2015. But none have been passed with any tangible changes. While the EWG has been accused of fear mongering and misleading consumers on the safety of naturally-derived ingredients, the silver lining is that they have empowered consumers to demand transparency, safe products, and social and environmental justice from cosmetics companies.</p><p>References</p><p><a href="https://www.vox.com/the-goods/2018/9/18/17866150/natural-clean-beauty-products-feinstein-cosmetics-bill-fda">https://www.vox.com/the-goods/2018/9/18/17866150/natural-clean-beauty-products-feinstein-cosmetics-bill-fda</a></p><p><a href="https://ec.europa.eu/jrc/sites/default/files/BISO-EnvSust-Bioproducts-13PDO_140930.pdf">https://ec.europa.eu/jrc/sites/default/files/BISO-EnvSust-Bioproducts-13PDO_140930.pdf</a></p><p><a href="https://www.govtrack.us/congress/bills/116/s726">https://www.govtrack.us/congress/bills/116/s726</a></p><p>Written by Kathleen Chen, PhD candidate at UCLA &amp; guest author for Helikon</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c0561f7eefae" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[State of the Industry]]></title>
            <link>https://admin-21183.medium.com/state-of-the-industry-8b4f5e2826b4?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/8b4f5e2826b4</guid>
            <category><![CDATA[global-meat-market]]></category>
            <category><![CDATA[biotechnology]]></category>
            <category><![CDATA[cellular-agriculture]]></category>
            <category><![CDATA[alternative-protein]]></category>
            <category><![CDATA[cultivated-meat]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Wed, 30 Jun 2021 12:52:37 GMT</pubDate>
            <atom:updated>2021-10-19T13:28:45.371Z</atom:updated>
            <content:encoded><![CDATA[<p>Business to Business Marketing Model Could Strengthen Cellular Agriculture: Scalability &amp; Investing in Ingredients</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*rc7oj0ucdzLUOsN7X131EA.png" /></figure><p><strong>Introduction</strong></p><p>The market for alternative proteins is one of the fastest up and coming markets today. According to the Good Food Institute, fermentation technology companies alone have garnered a $435 million investment in 2020 despite the coronavirus pandemic, and before the end of the calendar year. This is a 58% jump from 2019, which saw a $274 million investment in the field. This number expands to a $1.5 billion investment in alternative proteins more broadly, in 2020. According to Forbes magazine, the alternative protein market is projected to be worth $85 billion in 10 years, with a 28% compounded annual growth rate. The cultured meat industry is projected to be valued at $20 million by 2027. The products that result will not only be healthier and more sustainable, they will be produced more efficiently than traditional industrial meat and dairy products. Therefore, they will also be cheaper as the industry continues to make its way onto grocery store shelves and restaurant tables. As the industry continues to innovate, move forward, and expand, investment in B2B companies has the potential to strengthen the industry as it scales up. Without specific focus on each part of a product, the supply chain will likely fail to be able to keep up with desired production levels.</p><p>Consumer tendencies are not equal around the world when it comes to consuming meat. There is a powerful correlation between a country’s wealth and how much meat they consume; for instance, while the average American exceeded 200 pounds of meat consumed in 2019, India remained at the lowest average consumption rate at around 4 kilograms, or 8.8 pounds, per person. As reported by the United Nations, industrial agriculture uses upwards of 80 percent of the globe’s agricultural land, but accounts for around 18 percent of global calorie intake. This means that the meat industry, just by virtue of how it has to operate to fulfill consumer demands, takes a significant amount of land for only a portion of the global population. Now imagine that global meat consumption goes up 70 to 100 percent by 2050, as estimated by the Good Food Institute. What land will there be left to accommodate this drastic increase? Meat products sourced from plants or meat cultured from cells will be a necessary mode of production — and this isn’t considering compounding factors such as antibiotic resistance, greenhouse gas emissions, and ocean acidification from waste runoff, which all present their own compelling reasons for the reform of our agricultural system. A drastic shift in our agricultural practices is imperative to feed a population growing by the billions in the next 30 years, as well as to avoid a shortage of land and the destruction of our planet. In short, it is both a lucrative and a necessary investment.</p><p>The goal of this report is to explore the idea of how business to business marketing could drastically decrease the challenges of scalability.</p><p><strong>Overview of the Global Meat Market</strong></p><p><em>An overview of FAO’s Meat Market Review for 2020</em></p><p>McKinsey has estimated that the cultured meat market has the potential to be a $25 million market by 2030. The industry has garnered $250 million in investments in the first half of 2021, including those from Tyson and Nutreco. On average, global meat production was 337.2 million tonnes in 2020. Although prices fell throughout the pandemic, in August they began to rise — especially with demands for import by China and the Middle East. According to the FAO, global exports soared to 38.7 million tons, which was a 5.7% increase since 2019. Asia remains the country with the largest increase in imports, at a 15.8% increase and now accounting for 63% of meat imports. The FAO states that despite the pandemic, the globe’s top exporters, including the European Union, the United States, Brazil, Canada, Russia, and Mexico all exported more meat that the year before in 2019. Bovine meat, which includes beef, has fallen in the last year, mainly due to decreased prices and difficulties accessing stock. Although some countries were largely affected by the pandemic, Australia and Brazil exemplify a common trend in declining meat exports: past high volumes of slaughter of livestock was a factor in their low export ability in the last year. This indicates that there is a strain on the market due to overuse of livestock; while cellular agriculture is far from being an industry that “replaces” traditional farming, it’s capability to function as an “and/and” type of market would replenish traditional sources of meat and add sources of new meat with a no-kill version.</p><p>According to a June 2021 report on cultivated meat from McKinsey, production cost of cultivated proteins has gone down 99% in a decade. While achieving price parity is a challenge, the rates at which the industry has tackled that challenge create a bright outlook for the future. These current exorbitant prices are due to laboratory costs and expensive R&amp;D trials. By scaling the industry, it is thought that we can achieve a pound at below $5 US dollars. According to McKinsey, 75% of these costs could be eliminated by scaling the industry and 25% by “fine tuning” R&amp;D. The challenge is not seeing that we can get there, but how we will manage to scale and fine tune. Investing in ingredients and “one step” companies that hold expertise in single steps of the chain, is one way of refining the industry and of creating jobs.</p><p>Scalability is one of the largest challenges the cellular agriculture industry faces. As the industry grows, it will be important for companies to adapt in order to meet the demand to scale up. There are broad and unwieldy questions, such as how to produce cultivated meat on a global scale. Then there are the more nuanced questions, such as those of heat and energy costs dependent on location of bioprocessing facilities. For instance, what does heat and energy use look like if your bioprocess facility is in rural, hot Mexico, compared to urban, cold Canada?</p><p>The UN Environment Programme classifies food systems into three categories: traditional, modern, and intermediate. Most food systems are a hybrid of traditional and modern, hence the category intermediate. Traditional food systems involve farmers who use traditional agricultural or fishing practices — this type of market holds a local reach and does not use large scale production. Modern food systems are multi-step systems that rely on technology and various steps in a chain, and produce large quantities of packaged or processed foods for mass consumption. The UN states that a modern food system “typically consolidates the processing and food retail segments of the supply chain…and activities are increasingly of a transnational nature.” The globalization of our food systems took place in the 20th century, chiefly in industrialized continents such as Europe and North America.</p><p>These conventional, globalized systems have developed over decades in industrialized countries, whereas the cellular agriculture industry is in its infancy, comparatively. While the market for plant-based meat has grown from a national to a global market, cultivated meat is still on par with the UN’s “traditional” food system definition in terms of scope. Its reach consists of top chefs and a handful of selected subjects, who test its sales on the tables of their Michelin star restaurants (such as Just Eat’s cultivated chicken on the table of Singapore’s 1880). As Eric Schulze, VP of product and regulation at Memphis Meats, which according to the Good Food Institute raised a Series B round of \$186 M in 2020, is quoted in Nature saying: “Many companies have had the capacity to supply a single restaurant for a while. The goal is to get beyond that in terms of scale.” How will this sub-industry make its way into the national market, let alone a global market? How will it integrate itself into systems that have been operating for decades? These, among others, are the questions of tomorrow that many professionals and investors in the field are asking today.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/522/1*9C02NpspJeN0naYN_uK6hg.png" /></figure><p><strong>Upward Trends in Cultivated Meat</strong></p><p><em>Investing in Ingredients</em></p><p>Ingredients for alternative protein products can be perfected when specialized in. The regenerative medicine field has been operating this way for some time, with companies that specialize in <a href="https://www.biolifesolutions.com/">tools</a> for cell and gene therapy, <a href="https://www.orthocell.com.au/">collagen scaffolds</a>, and custom <a href="https://tevidobiodevices.com/">grafts</a> for regenerating skin color. Perfecting components of cultured meat products, such as fat, scaffolding, and protein will mean products reach taste, texture, and nutritional values with higher rates of consumer satisfaction. Companies such as Hoxton Farms, which raised 2.7 million pounds in their seed round in February 2021, specialize in slaughter free fat. The company Mission Barns raised another <a href="https://fortune.com/2021/04/07/kosher-bacon-mission-barns-lab-grown-fat-fundraising/">$24 million</a> for their lab grown fat in April 2021. According to the Kaplan Lab at Tufts University, there has been much more research done in muscle cells and tissue, rather than stand alone components such as fat. Fat as a stand alone ingredient is a vital part of the taste, texture, and now novel nutrition (replacing unhealthy saturated fat with Omega-3’s) of cultured meat. Creating fat in a lab requires scalable cell proliferation, stable adipogenic (fat) cell lines, cheaper growth media, and high density bioreactors to achieve industrial scale production.</p><p>The challenge is creating a market of companies that understand and have the resources to combine branding and marketing food, as well as specialized knowledge and research in the technology behind the foods. For instance, Impossible Foods was started by a Stanford University scientist who holds a PhD in biotechnology — not a combination of skills that is easily acquired or readily found. Therefore, companies such as the Boston based startup Motif, will be ones to watch. These are companies that are currently lower profile than Impossible Foods or Beyond Meat, but that will become vitally important for the industry in terms of specializing and streamlining it. Motif creates and provides ingredients made from fermentation and recombinant protein technologies, rather than tackle the complete process by creating a whole product from start to finish. Their slogan reads, “changing the ingredients changes everything,” and they bill themselves as “focusing on important sensory experiences that drive consumer enjoyment.” In this way, the industry is becoming specialized. If a startup like Motif can act as a vital step in the chain to a finished product, the cellular agriculture industry can modernize its reach, according to the food system definition from the UN. It will be important to consider access to these products — aspects such as who can access them, how they’ll access them, if those consumers have the financial stability to feel like they can choose this diet change, how educated consumers are on this switch, and which companies have consumer interests in mind.</p><p>A well known and long standing example of a B2B company is Perfect Day, who creates their own milk proteins, and partners with brands to create products like ice cream. On top of presenting a solution to scalability, partnerships have implications for collaboration between the alternative protein field and the traditional meat and dairy industries. This industry will not be successful in distributing its products without the market power that the traditional agriculture industry holds. Consumer acceptance will also struggle without the support of the traditional agriculture market, as people trust the brands they know far more readily.</p><p>Another example of a stand alone ingredient important to product success is scaffolding. Matrix Meats specializes in creating nanofiber scaffolding for cultured meat products. In January 2021, Matrix Meats was in a partnership with <a href="https://www.foodnavigator-usa.com/Article/2021/01/12/Nanofiber-scaffolding-startup-Matrix-Meats-in-active-development-relationships-with-14-cultivated-meat-producers">14</a> different cultured meat startups from seven countries. The company claims their scaffolding is customizable, and scaffolding is essential; without scaffolding, cultured meat loses its structure, which affects aspects like texture, consistency, and most importantly, shape. It’s what gives meat its soft but chewy bite, and fish its tenderness. It is a make or break component of cultivated meat products. Often, companies spend a substantial amount of time and testing different scaffolds, from mycelium to soy and collagen. This is a time consuming and costly process. More companies that specialize in essential elements like scaffolding, that can partner with cell cultured startups in a business to business marketing model, would increase efficiency, production, and consumer satisfaction. It would increase product value, if the resulting product is better than something a company could achieve on its own.</p><p>Israeli company Phyloton produces natural colors using fermentation that can be used in plant-based products such as the Impossible Burger. Color is another factor that plays into consumer acceptance. Fumi Ingredients specializes in egg ingredients. These are all examples of lesser known companies that will be imperative to scalability, as they each provide expertise in one, specific part of a product that they are working at perfecting and producing at large scale.</p><p>Investing in these companies is just as important as investing in those that create whole products, especially going forward with scalability in mind.</p><p><strong>Conscientious Consumerism &amp; Ethical Investment</strong></p><p>Conscientious consumerism is on the rise. It is the idea that consumers choose products based on moral values such as climate friendly, nutritious food, biodegradable packaging, slaughter-free choices, and so on.</p><p>Ethically sourced products have increasing purchasing power. A recent study from May 2021 proposes that 89% of Gen Z would try cultured meat, and 84–85% of millenials, with 80% overall acceptance. According to EY Parthenon, half of consumers studied, at 50%, said that climate and environment are important factors in their daily purchases. A 2020 study from Accenture, which was quoted in a BBC article about the pandemic’s power to transform consumer behavior, said that 60% of consumers were purchasing sustainably and ethically, with an estimated 9 out of</p><p>10 likely to continue doing so after the Covid 19 pandemic. In terms of what this means for the alternative proteins market, <a href="https://www.ey.com/en_us/food-system-reimagined/protein-reimagined-challenges-and-opportunities-in-the-alternative-meat-industry">EY</a> predicts an increase in the total market from between $5 and 10 billion, to an impressive $77 to $153 billion in 2030.</p><p><em>Investing in the New Definition of Value, and Business to Business Marketing</em></p><p>The definition of value in the food space has shifted from quantity to quality. There are new ideas when it comes to purchasing a food product: climate positive purchasing, healthy lifestyles, and ethical consumption. In terms of purchasing a product that is seen as an alternative, whether that be plant-based meat or cultured meat, it is imperative to this product’s success that it tastes good, feels good, and is nutritious. In the dawning age of ethical consumption on a mass scale, it is also important that the product be sustainable and ethically sourced. However, in the cellular agriculture space, these products are still inaccessible to many. Oftentimes, cell cultured products debut on the table of high end restaurants. While this method is currently the only mainstream manageable method for the scale of the industry, the definition of “high-value” is changing to en- compass the food we buy in the store down the street, as well as the expensive food we get on the table of a Michelin star. However, many companies rely on private funding. The cellular agricul- ture industry is in need of public funding to back research into components such as scaffolding and vascularization (producing cuts of meat with veins, an important part of nutritional value that the industry has not achieved yet).</p><p><strong>Recent B2B Interactions and Partnerships</strong></p><p>As Executive Director of New Harvest, Isha Datar, has commented in an article for Food Navi- gator, the Covid-19 pandemic has shown us how tenuous our food supply chain is. The cure she recommends is diversifying your business and exploring options to expand and continue your work. In the space of cellular agriculture, during a time when materials such as cell lines are in short supply, it is imperative that businesses find ways to lower costs and share resources through establishing B2B offshoots or partnerships. Partnerships and consortiums allow companies to sidestep buying pricey media from outside sources, creating their own scaffolding (which takes time and money), and tackling regulatory hurdles on their own.</p><p>On June 17, 2021, IntegriCulture announced their consortium CulNet, which launched April 1, 2021, where the cellular agriculture company is partnering with 12 companies so far. These com- panies range in expertise from growth media, scaffolds, and bioreactors. The goal is to create a supply chain and solve challenges such as scalability through open access innovation. IntegriCul- ture claims that this system can create cell types of any kind, create products that pass regulatory approval in many countries, and grow lines in serum that is less expensive than current growth media options. This type of small scale supply chain is an example of multiple partnerships that could help the industry scale. IntegriCulture has been pursuing this track for some time. In 2020, Shiok Meats and IntegriCulture partnered to tackle growth media. The partnership allows them to culture seafood, for less. IntegriCulture will provide “SpaceSalt,” the growth media made in the partnership, and will allow Shiok to leverage the technology that IntegriCulture has.</p><p>In another June 2021 development, Geltor partnered with Lonza Specialty Ingredients to create a food product called PrimaColl. It will be a collagen product that initiates the production of more collagen in the body. This is a fitting first food product for Geltor, as they have worked with collagen in the cosmetic industry before. In January of this year in 2021, Turtle Tree Labs started a B2B offshoot of their cellular agriculture company, which will be specializing in growth factors for the industry. The goal of this offshoot will be to lower costs of growth factors for the industry as a whole, making cultured protein products more accessible across the board, rather than internally. This discourages a monopoly on the market, and has implications for lowering costs which are currently expensive enough that it is putting a block on product development. Peace of Meat, who makes fat for cultivated meat, joined with MeaTech.</p><p>All of these examples are important pioneers of the cellular agriculture supply chain. They are foundational for the next stage in the cellular agriculture industry, which will likely need to reflect IntegriCulture’s consortium, or Geltor’s assistance from Lonza to branch into the food space.</p><p><strong>A Challenge to the Market</strong></p><p>A persistent challenge to the current market is the funding gap. The funding gap in cellular agriculture refers to the gap between public and private funding, where private funding far exceeds public funding. This means that while a pipeline from investors to private companies is being established, research at the university level can get left behind. This often means that the research in academic papers is older than the science that continues to develop each day “in house,” or within companies. The more research into specific components that can be used for B2B interactions, the better the outcome for product and consumer acceptance.</p><p><em>Funding could:</em></p><ul><li>Make cell lines publicly available. Researchers often have to either <a href="https://www.nature.com/articles/d41586-019-00373-w">substitute </a>bovine, poultry, or swine cells with mouse cells, or get cell lines from a slaughterhouse. This is inefficient for a lot of companies as they scale up.</li><li>Back fundamental research: the first cultured hamburger, developed by Mark Post in 2013, ultimately came out of government funding that the “father” of cellular agriculture, Willem Van Eelen, convinced the Dutch government to give.</li><li>Ease regulatory debates as more research into products’ nutritional components and ingredient lists becomes available</li><li>Research into specific B2B components such as scaffolds, cultivated fat, vascularization (making sure the meat has veins so nutrient circulation can happens.</li></ul><p><em>References</em></p><p>Dolgin, Elie. “Sizzling interest in lab-grown meat belies lack of basic research.” <em>Nature</em>, February 3, 2019.</p><p>“Cellular Agriculture Companies.” CellAgri. <a href="https://www.cell.ag/companies">https://www.cell.ag/companies</a>.</p><p><a href="https://www.ey.com/en_us/people/rob-dongoski">Rob Dongoski</a>, EY Food and Agriculture Leader, Mark Holland, Principal, EY-Parthenon, Ernst &amp; Young LLP, Brian Bourquard, Senior Director, EY-Parthenon, Ernst &amp; Young LLP, Paul Ritch, Senior Consultant, Ernst &amp; Young LLP. EY Parthenon. April 1, 2021. <a href="https://www.ey.com/en_us/food-system-reimagined/protein-reimagined-challenges-and-opportunities-in-the-alternative-meat-industry.">https://www.ey.com/en_us/food-system-reimagined/protein-reimagined-challenges-and-opportunities-in-the-alternative-meat-industry.</a></p><p>Forbes. Last modified March 3, 2020. 3 Trends to Watch in Alternative Protein. <a href="https://www.forbes.com/sites/tommytobin/2020/03/03/3-trends-to-watch-in-alternative-proteins-for-2020/?sh=3c89a0123503">https://www.forbes.com/sites/tommytobin/2020/03/03/3-trends-to-watch-in-alternative-proteins-for-2020/?sh=3c89a0123503</a>.</p><p>“Uni-CulNet.” IntegriCulture. <a href="https://integriculture.jp/product/?locale=en.">https://integriculture.jp/product/?locale=en.</a></p><p>“$1.5 Billion Invested in Alternative Proteins in 2020, Including a Record $435 Million in the next Pillar — Fermentation.” <em>The Good Food Institute</em>, <a href="https://www.gfi.org/alternative-protein-fermentation-investments-2020-media-release#:~:text=GFI%27s%20report%20analyzes%20investment%20activity,as%20Covid%2D19%20disrupted%20global.">https://www.gfi.org/alternative-protein-fermentation-investments-2020-media-release#:~:text=GFI%27s%20report%20analyzes%20investment%20activity,as%20Covid%2D19%20disrupted%20global.</a> Accessed 25 Nov. 2020.</p><p><em>‘It’s Our Job to Evolve with Consumers’: Tyson Foods on Alternative Protein | McKinsey</em>. <a href="https://www.mckinsey.com/industries/consumer-packaged-goods/our-insights/its-our-job-to-evolve-with-consumers-tyson-foods-on-alternative-protein.">https://www.mckinsey.com/industries/consumer-packaged-goods/our-insights/its-our-job-to-evolve-with-consumers-tyson-foods-on-alternative-protein.</a> Accessed 25 Nov. 2020.</p><p>Watson, Elaine. “Nanofiber scaffolding startup Matrix Meats in ‘active development relationships with 14 cultivated meat producers.’” <em>Food Navigator</em>, January 12, 2021.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8b4f5e2826b4" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[On the Horizon: The integration of adipocytes into 3D cultured meat]]></title>
            <link>https://admin-21183.medium.com/on-the-horizon-the-integration-of-adipocytes-into-3d-cultured-meat-f74847e23bc9?source=rss-a4e32a83d306------2</link>
            <guid isPermaLink="false">https://medium.com/p/f74847e23bc9</guid>
            <category><![CDATA[adipocyte]]></category>
            <category><![CDATA[3d]]></category>
            <category><![CDATA[cultured]]></category>
            <category><![CDATA[alternative-protein]]></category>
            <category><![CDATA[cultured-meat]]></category>
            <dc:creator><![CDATA[Helikon Consulting]]></dc:creator>
            <pubDate>Wed, 30 Jun 2021 12:36:34 GMT</pubDate>
            <atom:updated>2021-06-30T12:36:34.407Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*O-VYP_7te-gdx2qRr4B6ag.jpeg" /></figure><p>Fat is a key component of a flavorful and juicy piece of meat. In a study done by <a href="https://www.fooddive.com/news/how-taste-protein-and-ingredients-are-barriers-to-plant-based-meat-adoptio/567356/">Kerry</a>, taste takes precedence: 73% of consumers surveyed named it as a must have feature for alternative protein. Healthy fats are also an accepted and sought after component of a comprehensive diet, after years of “low-fat” products. Most species-specific flavors are attributed to the profile of fatty acids in the meat and also lipophilic, or fat-soluble, components1. Only around 20% of the fat found in meat is located within muscle cells themselves while the other 80% comes from intramuscular adipocytes, or fat cells2. As a recent Forbes article wrote, “hungry investors should focus their appetite on the juiciest bit: cultured <a href="https://www.forbes.com/sites/danieladelorenzo/2021/05/25/lab-grown-meats-cultured-fat-is-where-business-gets-juicy/?sh=64ab79db1401">fat</a>.” The juicy sizzle of a hamburger or steak that hits the grill is what’s lacking in many plant based options. It’s what entices the consumer in smell, taste, sound, and texture. Giving a consumer a palatable, complete experience that is the same as or better than a traditional cut of meat is imperative for the industry’s success. For cell cultured meat, which is real meat, fat is a must have feature. The challenge will be culturing muscle and fat together, as this co-culturing process has challenges such as cost as well as chemistry hurdles in the lab. Although many companies in the space are actively involved in R&amp;D to generate cultivated fat, only a few have debuted products containing co-cultured muscle and fat cells. Most notably, Aleph Farms, with a total of $14.4 M in funding according to Crunchbase, announced the successful development of a 3D bioprinted steak containing both muscle and fat cells this past February3. Other companies developing cultivated fat include Hoxton Farms, Mission Barns, and Meatable, among others. As the cultured meat industry moves towards creating whole 3D cuts of meat, incorporating fat will be increasingly important for delivering realistic marbling, taste, and texture.</p><p><strong>Advantages of Cultured Fat</strong></p><p>There are several reasons related to product quality that make cultivated fat development worthwhile, and companies are choosing to invest considerable amounts to achieve these integrated products. The taste and textural improvement of cultured meat is one of the largest advantages. Fat is extremely important for delivering essential flavor components. Fats from vegetable sources that are used in plant-based meat typically do not contain components or lipid profiles that match conventional meat12. <strong>For this reason, fat derived from animal adipocytes would be the ideal way to convey a similar taste profile to conventional meat.</strong> Additionally, plant-based fats typically have lower melting temperatures and thus meat containing these fats would behave differently during the cooking process, and ultimately have an impact on juiciness and texture12.</p><p>Another more infrequently discussed advantage of cultivated fat is the potential for minimizing the intake of environmental pollutants which are found in the fat of conventional meat. These pollutants are particularly dangerous because of their ability to bioaccumulate in both animal and human fat tissue13. Cultivation of fat would allow for more control over input and the ability to reduce or completely eliminate these toxins from cultured meat. Mission Barns, which has $28.2 M in funding according to Crunchbase, highlights this capability on their website, comparing conventional meat which may contain heavy metals and toxins to their products which contain none. As certain of these toxins have been linked to cancer, endocrine dysfunction, and reproductive and developmental defects, removing dietary sources of these persistent environmental toxins would be of great benefit to human health14. These safety and health advantages over conventional meat could be marketed to consumers to persuade either a transition from conventional to cultured meat, or an incorporation into their current diet.</p><p><strong>Brief Background on Adipocytes (fat cells) and Differentiation</strong></p><p>Adipocytes, or fat cells, play key roles in energy storage in the form of lipid droplets and are important mediators of endocrine signaling and communication with other tissues to regulate metabolic processes. In animals, adipocytes are found throughout the body, surrounding most organs and tissue types including muscle. White adipocytes originate from stem cells which can be differentiated to pre-adipocyte cells and then further to mature adipocytes which are capable of storing lipids.</p><p>In an academic or biomedical research setting, pre-adipocytes, or pre-fat cells, are induced to become mature adipocytes through treatment with insulin, steroids, and antidiabetic drugs like rosiglitazone. These chemicals would not be appropriate for cultured meat and food related processes. Alternative and food-compatible methods of adipocyte differentiation do exist, however. Treatment of bovine adipogenic precursor cells (basically baby fat cells) with fatty acids from vegetable oils has been shown to lead to differentiation and maturation of bovine adipocytes (fat cells in cows)4.</p><p><strong>Co-culture Strategies and Potential Complications</strong></p><p>Culturing cells in large batches has been a feature solely of the biomedical industry until fairly recently. For medical purposes, adipocyte tissue engineering has been used for soft tissue regeneration. Often, growing fat in an environment that is conducive to culturing fat and muscle cells together is time consuming and costly. When it comes to the incorporation of fat cells into muscle tissue for cultivated meat products, companies have two methodological choices: (1) culture muscle and fat separately and then combine, or (2) co-culture muscle and fat precursor cells together and utilize a differentiation media which works for both cell types. Both approaches maintain their own set of difficulties.</p><p>If the goal is to create a whole cut of meat, it is important that an investment is made into a scaffold, or framework for the fat to grow on, that can support growing muscle and fat together. One challenge that will need to be confronted when choosing a scaffold is that fat and muscle cells need different levels of environmental stiffness during the growth process. Fat cells are typically quite fragile and prone to floating, two properties that make them difficult to work with. Finding a company or scientist that is familiar with these finicky properties is imperative to the success of culturing fat. These processes may require diligent practices to delicately manipulate the two cell types, muscle and fat. Recent advancements in the field of adipose, or fat, tissue engineering have explored the possibility of bioprinting mature fat cells or fat cell clusters 6,7. With the right bioink to encapsulate the cells and proper printing conditions, fat cells remained viable during and following the bioprinting process. These publications illustrate the potential for utilizing bioprinting to combine mature fat cells with muscle cells in a patterned manner. Bioprinting is a promising way to skirt the challenge of integrating muscle and fat.</p><p>Another historical difficulty of a muscle and fat cell co-culture approach is the ability of one cell type to influence the behavior of the other. Research shows that the growth rate and gene expression profiles of myoblasts (muscle precursor cells) are altered when cultured in the presence of fat cells. This is likely due to the secretion of specific proteins acting as signaling molecules that are sensed by the other cell type and influence their function. These have been known to promote gene expression that codes for fat cells in premature muscle cells, and alter cell metabolism. One study found that co-culture of mature fat cells and muscle cells from mice leads to the domination of the culture by the fat cells, and reduces the ability of the muscle cells to grow and multiply in a proper way9. Such results suggest possible obstacles in achieving efficient muscle differentiation and maturation with this approach, although the effects of these secreted signaling factors could potentially be minimized by frequent cycling and filtering of media. The challenge here will be growth media costs, as a company may not have the bandwidth to constantly cycle their media.</p><p>At this stage both of the proposed strategies appear to be viable options and are employed by various early stage cultivated meat companies. Ivy Farm Technologies, using the first tactic, grows each cell type separately before combining to create the final product10. On the other hand, Meatable, which has $62.9 M in funding according to Crunchbase, has developed stem cells that can be grown together to form both muscle and fat.11 As scaffold technologies and media formulations improve it will be interesting to see what new methods for co-culture arise.</p><p><strong>Concluding Remarks</strong></p><p>As the cultured meat industry grows and companies approach the point of commercial release of products, fat sources that contribute the flavors and texture of conventional meat fat will be necessary to draw new consumers to their products. The integration of fat cells with muscle cells will be even more important in recreating realistic whole cuts of meat. With innovations in tissue engineering on the rise, many of the large and immediate challenges of 3D cultured meat are being tackled, including vascularization (making sure nutrients can move around the tissue) and scaffolding, allowing for more focus on developing these downstream incorporation strategies. The implementation of novel co-culture tactics and technology will be required to overcome the discussed historical difficulties associated with these approaches; however the result will presumably be well worth the investment in innovation.</p><p><strong>References</strong></p><p>1. Walker EL, Hudson MD. <em>Encyclopedia of Meat Sciences</em>.; 2014.</p><p>2. Ben-Arye T, Levenberg S. Tissue Engineering for Clean Meat Production. <em>Front Sustain Food Syst</em>. 2019;3:46. doi:10.3389/fsufs.2019.00046</p><p>3. Bandoim L. World’s First 3D Bioprinted And Cultivated Ribeye Steak Is Revealed. Published February 12, 2021. Accessed June 4, 2021. <a href="https://www.forbes.com/sites/lanabandoim/2021/02/12/worlds-first-3d-bioprinted-and-cultivated-ribeye-steak-is-revealed/?sh=5ef53c764781">https://www.forbes.com/sites/lanabandoim/2021/02/12/worlds-first-3d-bioprinted-and-cultivated-ribeye-steak-is-revealed/?sh=5ef53c764781</a></p><p>4. Mehta F, Theunissen R, Post MJ. Adipogenesis from bovine precursors. In: <em>Methods in Molecular Biology</em>. Vol 1889. Humana Press Inc.; 2019:111–125. doi:10.1007/978–1–4939–8897–6_8</p><p>5. Post MJ, Levenberg S, Kaplan DL, et al. Scientific, sustainability and regulatory challenges of cultured meat. <em>Nat Food 2020 17</em>. 2020;1(7):403–415. doi:10.1038/s43016–020–0112-z</p><p>6. Louis F, Piantino M, Liu H, et al. Bioprinted Vascularized Mature Adipose Tissue with Collagen Microfibers for Soft Tissue Regeneration. <em>Cyborg Bionic Syst</em>. 2021;2021:1–15. doi:10.34133/2021/1412542</p><p>7. Colle J, Blondeel P, De Bruyne A, et al. Bioprinting predifferentiated adipose-derived mesenchymal stem cell spheroids with methacrylated gelatin ink for adipose tissue engineering. <em>J Mater Sci Mater Med</em>. 2020;31(4):1–15. doi:10.1007/s10856–020–06374-w</p><p>8. Kuppusamy P, Kim D, Soundharrajan I, Hwang I, Choi KC. Adipose and muscle cell co-culture system: A novel in vitro tool to mimic the in vivo cellular environment. <em>Biology (Basel)</em>. 2021;10(1):1–12. doi:10.3390/biology10010006</p><p>9. Seo K, Suzuki T, Kobayashi K, Nishimura T. Adipocytes suppress differentiation of muscle cells in a co-culture system. <em>Anim Sci J</em>. 2019;90(3):423–434. doi:10.1111/asj.13145</p><p>10. Morrison O. UK start-up predicts lab-grown sausages on shelves by 2023 after technology ‘breakthrough.’ Published May 19, 2021. Accessed June 4, 2021. <a href="https://www.foodnavigator.com/Article/2021/05/19/UK-start-up-predicts-lab-grown-sausages-on-shelves-by-2023-after-technology-breakthrough">https://www.foodnavigator.com/Article/2021/05/19/UK-start-up-predicts-lab-grown-sausages-on-shelves-by-2023-after-technology-breakthrough</a></p><p>11. Ellis J. Meatable banks $47m from DSM, others for its cellular pork &amp; beef. Published March 25, 2021. Accessed June 4, 2021. <a href="https://agfundernews.com/meatable-banks-47m-from-dsm-others-to-realize-the-pluri-potential-of-its-cellular-pork-beef.html">https://agfundernews.com/meatable-banks-47m-from-dsm-others-to-realize-the-pluri-potential-of-its-cellular-pork-beef.html</a></p><p>12. Southey F. Cultivating animal fat for plant-based meat: ‘Nobody wants a burger that tastes of coconut.’ Published March 4, 2021. Accessed June 22, 2021. <a href="https://www.foodnavigator.com/Article/2021/03/04/Cultivating-animal-fat-for-plant-based-meat-Nobody-wants-a-burger-that-tastes-of-coconut">https://www.foodnavigator.com/Article/2021/03/04/Cultivating-animal-fat-for-plant-based-meat-Nobody-wants-a-burger-that-tastes-of-coconut</a></p><p>13. Guo W, Pan B, Sakkiah S, et al. Persistent organic pollutants in food: Contamination sources, health effects and detection methods. <em>Int J Environ Res Public Health</em>. 2019;16(22). doi:10.3390/ijerph16224361</p><p>14. Kogevinas M. Human health effects of dioxins: Cancer, reproductive and endocrine system effects. <em>Hum Reprod Update</em>. 2001;7(3):331–339. doi:10.1093/humupd/7.3.331</p><p>Written by Anna Goddi, Associate &amp; Thea Burke, Strategist for Helikon Consulting</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f74847e23bc9" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>